Home | Overview of gut regions | Anatomy | Histology | Transgene expression mapping | Gene expression |
Mean expression enrichment by gut region
Filter out everything which GO terms when the expression scale ratio is comprised between -1.5 and 1.5 for all regions |
GO term | Number of genes | Crop / Full gut |
R2 / Full gut |
R3 / Full gut |
R4 / Full gut |
R5 / Full gut |
Hindgut / Full gut |
Cardia/R1 / Full gut |
---|---|---|---|---|---|---|---|---|
exocyst | 6 | -1.08 | 1.29 | 1.41 | 1.24 | 1.37 | 1.05 | 1.07 |
M phase | 379 | 1.18 | 1.09 | 1.2 | 1.09 | 1.24 | 1.18 | 1.08 |
protein deneddylation | 3 | 1.57 | -1.01 | 1.18 | 1.14 | 1.14 | 1.07 | -1.1 |
cell morphogenesis | 428 | 1.11 | 1.09 | 1.24 | 1.04 | 1.25 | 1.24 | 1.24 |
stress fiber | 1 | 1.76 | 1.07 | 1.13 | 1.08 | 1.49 | 1.28 | 1.15 |
glycoprotein binding | 1 | 3.21 | -1.21 | 1.67 | 1.12 | 1.32 | 6.4 | 2.23 |
lymphocyte mediated immunity | 2 | -2.37 | 1.1 | 1.16 | -1.04 | 1.34 | -1.89 | 1.24 |
renal sodium ion transport | 1 | -52.82 | -1.7 | -31.49 | 1.13 | -9.63 | 16.55 | -13.85 |
molecular_function | 8833 | 1.01 | -1.01 | 1.0 | 1.01 | 1.05 | 1.02 | -1.0 |
ferrochelatase activity | 1 | 1.62 | 1.26 | 1.09 | -1.07 | 1.01 | 1.21 | 1.32 |
mesoderm development | 91 | 1.26 | -1.02 | 1.08 | -1.05 | 1.17 | 1.32 | 1.03 |
RNA splicing | 186 | 1.18 | 1.12 | 1.22 | 1.22 | 1.31 | 1.16 | 1.02 |
nicotinamidase activity | 1 | -2.04 | 1.72 | -1.29 | 1.07 | 1.25 | 4.26 | 2.23 |
lipoate biosynthetic process | 2 | 1.65 | 1.07 | 1.42 | 1.08 | 1.12 | 2.67 | -1.13 |
FMN binding | 10 | 1.36 | 1.09 | 1.23 | 1.12 | -1.05 | 1.11 | -1.08 |
response to UV-B | 1 | 1.85 | -1.14 | 1.04 | 1.61 | 1.1 | 1.04 | 1.04 |
ectodermal cell differentiation | 2 | 4.98 | -1.19 | 1.75 | -1.46 | 1.16 | 1.31 | 1.35 |
vesicle membrane | 23 | -1.12 | 1.13 | 1.13 | 1.07 | 1.16 | 1.18 | 1.23 |
nuclear matrix | 3 | -1.0 | 1.28 | 1.38 | 1.16 | 1.24 | 1.52 | 1.32 |
ceramidase activity | 2 | -7.56 | -2.15 | -1.17 | 1.28 | -1.14 | -15.17 | -6.93 |
acyl-CoA delta11-desaturase activity | 1 | -3.53 | -3.34 | -2.71 | -4.29 | -3.06 | -2.31 | 4.71 |
peptidyl-serine modification | 3 | 1.28 | 1.07 | 1.17 | 1.15 | 1.14 | 1.08 | -1.08 |
cytokine binding | 3 | 1.17 | 1.12 | 1.1 | 1.02 | 1.54 | 1.2 | 1.72 |
T-tubule | 1 | 1.33 | 1.32 | 2.26 | 1.11 | 1.52 | 1.39 | 1.48 |
autosome | 1 | 1.07 | 1.1 | 1.33 | 1.13 | 1.37 | -1.12 | 1.05 |
A band | 9 | 1.95 | -1.09 | -1.15 | -1.11 | 1.13 | 1.79 | 1.07 |
cleavage furrow | 9 | -1.04 | 1.09 | 1.57 | 1.01 | 1.45 | 1.33 | 1.15 |
macromolecule localization | 473 | 1.01 | 1.1 | 1.21 | 1.1 | 1.24 | 1.12 | 1.09 |
ESCRT-0 complex | 2 | -1.75 | 1.13 | 2.24 | 1.06 | 1.39 | 1.34 | 1.26 |
ribosome localization | 1 | 2.15 | -1.01 | 1.44 | 1.25 | 1.44 | 1.28 | 1.21 |
protein localization in Golgi apparatus | 10 | -1.16 | 1.12 | 1.17 | 1.04 | 1.21 | 1.41 | 1.65 |
pupation | 4 | 2.01 | -1.05 | 1.24 | -1.24 | 1.14 | 2.15 | 1.25 |
DNA dealkylation | 1 | 1.12 | -1.01 | 1.19 | 1.74 | 1.2 | 1.06 | -1.09 |
AP-2 adaptor complex binding | 1 | 1.51 | 1.33 | 2.01 | 1.25 | 1.81 | 2.91 | 1.9 |
cargo receptor activity | 36 | 1.1 | -1.14 | -1.08 | -1.02 | -1.03 | 1.05 | -1.08 |
regulation of growth | 153 | 1.13 | 1.15 | 1.39 | 1.07 | 1.32 | 1.3 | 1.24 |
DNA protection | 1 | 1.02 | -1.01 | 1.31 | 1.02 | 1.58 | 1.3 | 1.2 |
presynaptic membrane | 8 | -1.25 | 1.03 | 1.27 | -1.02 | 1.34 | 1.8 | 1.18 |
fibril | 1 | 1.02 | -1.0 | 1.14 | 1.18 | 1.1 | 1.03 | -1.08 |
DNA hypermethylation | 3 | 1.11 | 1.01 | 1.05 | 1.05 | 1.09 | 1.06 | -1.09 |
main axon | 2 | -1.07 | -1.38 | -1.02 | -1.09 | 1.18 | 3.54 | 1.59 |
actin nucleation | 4 | -2.38 | 1.35 | 1.23 | 1.09 | 1.22 | -1.94 | 1.21 |
negative regulation of S phase of mitotic cell cycle | 11 | 1.34 | 1.21 | 1.41 | 1.15 | 1.44 | 1.65 | 1.53 |
imaginal disc fusion | 16 | 1.01 | 1.24 | 1.46 | 1.12 | 1.3 | 1.23 | 1.22 |
female sex differentiation | 19 | 1.28 | 1.1 | 1.09 | 1.01 | 1.21 | 1.14 | 1.12 |
protein autophosphorylation | 7 | -1.02 | 1.18 | 1.21 | 1.11 | 1.22 | 1.16 | 1.21 |
habituation | 4 | 1.3 | -1.01 | 1.62 | 1.18 | 1.4 | 1.83 | 1.26 |
eye pigmentation | 34 | 1.13 | -1.1 | -1.23 | 1.11 | 1.01 | -1.18 | -1.07 |
chromosome localization | 18 | 1.21 | 1.05 | 1.2 | 1.17 | 1.42 | 1.12 | -1.0 |
localization | 1626 | -1.02 | 1.02 | 1.05 | 1.01 | 1.11 | 1.1 | 1.04 |
actin crosslink formation | 1 | 2.2 | 1.13 | -1.01 | 1.18 | 1.16 | -1.08 | 1.17 |
glycolipid binding | 1 | -2.99 | 1.35 | -1.24 | 1.41 | -1.1 | -2.55 | -1.06 |
catecholamine transport | 2 | 3.07 | -1.44 | -1.47 | -1.28 | -1.45 | -1.2 | -1.42 |
carboxylic ester hydrolase activity | 99 | -1.69 | -1.12 | -1.47 | -1.07 | -1.31 | -2.03 | -1.33 |
foraging behavior | 1 | -12.04 | -1.69 | 9.34 | -2.59 | -11.09 | -12.8 | -6.11 |
regulation of canonical Wnt receptor signaling pathway | 6 | 1.19 | 1.08 | 1.68 | 1.07 | 1.07 | 1.06 | 1.46 |
establishment of blood-brain barrier | 19 | 2.5 | -1.26 | 1.24 | -1.17 | 1.21 | 2.3 | 1.4 |
neuroendocrine cell differentiation | 2 | -1.09 | 1.14 | 1.11 | 1.1 | 1.07 | -1.24 | 1.07 |
Wnt protein secretion | 1 | 1.86 | -1.05 | 2.03 | 1.04 | 1.26 | 2.03 | 1.19 |
vitamin B6 binding | 40 | 1.01 | 1.02 | -1.27 | -1.04 | -1.03 | -1.02 | 1.04 |
RISC-loading complex | 1 | 1.44 | 1.23 | 1.89 | 1.19 | 2.25 | 1.64 | 1.56 |
cellular response to ecdysone | 11 | 1.32 | 1.19 | 1.43 | 1.13 | 1.47 | 1.53 | 1.33 |
circulatory system development | 70 | 1.28 | -1.02 | 1.19 | -1.07 | 1.17 | 1.3 | 1.17 |
regulation of ion homeostasis | 3 | 1.14 | 1.14 | 1.39 | 1.16 | 1.04 | 1.71 | 1.47 |
mitochondrial genome maintenance | 8 | -1.05 | 1.17 | 1.44 | 1.18 | 1.23 | 1.21 | -1.27 |
reproduction | 846 | 1.12 | 1.06 | 1.15 | 1.03 | 1.18 | 1.14 | 1.14 |
ribosome biogenesis | 52 | 1.28 | 1.16 | 1.24 | 1.3 | 1.29 | 1.06 | 1.05 |
protein binding involved in protein folding | 2 | 1.49 | 1.24 | 1.02 | 1.11 | 1.08 | 1.24 | 1.18 |
unfolded protein binding | 80 | 1.1 | 1.04 | 1.1 | 1.14 | 1.14 | 1.02 | -1.05 |
protein thiol-disulfide exchange | 1 | -1.26 | 1.49 | 1.56 | 1.08 | 1.23 | -1.31 | 1.33 |
disulfide oxidoreductase activity | 30 | 1.14 | 1.05 | -1.02 | 1.16 | 1.09 | -1.11 | -1.1 |
alpha-1,6-mannosyltransferase activity | 1 | 1.2 | 1.3 | 1.28 | 1.05 | 1.27 | 1.14 | 1.6 |
trans-hexaprenyltranstransferase activity | 2 | 2.38 | 1.18 | 1.12 | 1.03 | 1.43 | 1.86 | 1.15 |
single strand break repair | 2 | 1.23 | 1.1 | 1.14 | 1.12 | 1.12 | 1.05 | 1.04 |
single-stranded DNA specific endodeoxyribonuclease activity | 3 | 1.42 | 1.05 | 1.38 | 1.12 | 1.4 | 1.2 | -1.23 |
phosphopyruvate hydratase complex | 1 | 1.97 | 1.06 | -1.39 | -1.17 | -1.32 | 2.59 | 1.17 |
alpha-glucoside transport | 2 | 1.24 | -2.16 | -1.19 | -2.0 | -1.13 | 3.38 | 1.3 |
regulation of DNA recombination | 2 | -1.59 | 1.15 | 1.13 | 1.19 | 1.42 | -1.74 | -1.31 |
regulation of mitotic recombination | 1 | -2.02 | 1.1 | 1.06 | 1.2 | 1.9 | -2.66 | -1.77 |
negative regulation of mitotic recombination | 1 | -2.02 | 1.1 | 1.06 | 1.2 | 1.9 | -2.66 | -1.77 |
mitotic spindle elongation | 72 | 1.4 | 1.08 | 1.2 | 1.04 | 1.24 | 1.24 | 1.15 |
alpha-1,2-mannosyltransferase activity | 1 | -1.58 | 1.15 | -1.08 | 1.11 | -1.2 | -1.77 | 1.49 |
mannosyltransferase activity | 12 | -1.24 | 1.17 | 1.3 | 1.07 | 1.33 | -1.21 | 1.12 |
acyl carrier activity | 6 | 1.59 | 1.03 | 1.12 | 1.01 | 1.14 | 1.4 | 1.17 |
very long-chain fatty acid metabolic process | 5 | 3.63 | -2.39 | -2.2 | -3.1 | -1.91 | -1.08 | 3.71 |
long-chain fatty acid transporter activity | 7 | -2.15 | 1.3 | -1.32 | -1.52 | -2.35 | -1.39 | -1.5 |
plasma membrane | 575 | 1.16 | 1.01 | 1.11 | -1.03 | 1.11 | 1.23 | 1.16 |
transition metal ion transport | 17 | 1.11 | 1.0 | 1.11 | -1.05 | -1.09 | 1.21 | 1.05 |
protein targeting to Golgi | 10 | -1.16 | 1.12 | 1.17 | 1.04 | 1.21 | 1.41 | 1.65 |
autophagic vacuole assembly | 2 | 1.21 | 1.14 | -1.0 | 1.38 | 1.03 | -1.03 | -1.25 |
autophagic vacuole fusion | 2 | 1.14 | 1.16 | 1.85 | 1.13 | 1.26 | 1.5 | 1.09 |
electron carrier activity | 154 | -1.07 | -1.09 | -1.18 | -1.02 | 1.01 | -1.08 | -1.1 |
tRNA binding | 9 | 1.2 | 1.27 | 1.24 | 1.22 | 1.15 | 1.15 | 1.01 |
urea cycle | 1 | -31.89 | 1.77 | -20.72 | 1.41 | 1.0 | -12.66 | -3.5 |
argininosuccinate metabolic process | 1 | -31.89 | 1.77 | -20.72 | 1.41 | 1.0 | -12.66 | -3.5 |
ribosomal subunit export from nucleus | 1 | 2.15 | -1.01 | 1.44 | 1.25 | 1.44 | 1.28 | 1.21 |
ribosomal large subunit export from nucleus | 1 | 2.15 | -1.01 | 1.44 | 1.25 | 1.44 | 1.28 | 1.21 |
protein import into nucleus, docking | 2 | -1.85 | 1.21 | 1.23 | 1.37 | 1.53 | -1.37 | -1.23 |
protein import into nucleus, translocation | 2 | 1.98 | -1.11 | 1.05 | 1.22 | 1.33 | 2.03 | -1.05 |
fatty-acyl-CoA binding | 8 | -2.25 | -1.27 | -1.85 | 1.18 | 1.35 | -2.52 | -1.44 |
L-ornithine transmembrane transporter activity | 1 | 1.32 | 1.45 | -1.5 | 1.71 | 1.05 | 1.03 | -1.1 |
mitochondrial ornithine transport | 1 | 1.32 | 1.45 | -1.5 | 1.71 | 1.05 | 1.03 | -1.1 |
DNA replication | 73 | 1.08 | 1.13 | 1.19 | 1.17 | 1.34 | 1.13 | -1.02 |
chromosome segregation | 124 | 1.15 | 1.1 | 1.25 | 1.11 | 1.3 | 1.2 | 1.1 |
chromosome organization | 265 | 1.2 | 1.11 | 1.27 | 1.13 | 1.32 | 1.2 | 1.15 |
mitotic sister chromatid segregation | 55 | 1.25 | 1.07 | 1.29 | 1.1 | 1.36 | 1.27 | 1.09 |
M phase specific microtubule process | 1 | 1.59 | 1.65 | -1.13 | 1.13 | 1.0 | -1.46 | -1.04 |
cell cycle checkpoint | 84 | 1.23 | 1.14 | 1.35 | 1.19 | 1.41 | 1.29 | 1.15 |
DNA replication checkpoint | 3 | -1.03 | -1.02 | 1.14 | 1.12 | 1.37 | 1.02 | -1.1 |
DNA damage checkpoint | 69 | 1.23 | 1.15 | 1.38 | 1.19 | 1.41 | 1.31 | 1.15 |
regulation of cyclin-dependent protein kinase activity | 15 | 1.32 | 1.16 | 1.36 | 1.2 | 1.41 | 1.07 | 1.15 |
G1 phase of mitotic cell cycle | 1 | -1.2 | 1.72 | 1.55 | 1.31 | 1.53 | 1.21 | 1.72 |
G1/S transition of mitotic cell cycle | 14 | 1.35 | 1.24 | 1.43 | 1.21 | 1.54 | 1.24 | 1.25 |
regulation of transcription involved in G1/S phase of mitotic cell cycle | 1 | 1.31 | 1.43 | 1.45 | 1.16 | 1.14 | 1.54 | 1.46 |
S phase of mitotic cell cycle | 3 | -1.1 | 1.13 | 1.05 | 1.24 | 1.2 | -1.11 | -1.1 |
astral microtubule | 4 | -1.02 | 1.17 | 1.36 | -1.01 | 1.32 | 1.27 | 1.24 |
G2 phase of mitotic cell cycle | 1 | 1.67 | 1.26 | 1.32 | 1.4 | 1.23 | 1.13 | 1.21 |
G2/M transition of mitotic cell cycle | 71 | 1.21 | 1.14 | 1.34 | 1.19 | 1.41 | 1.24 | 1.13 |
M phase of mitotic cell cycle | 148 | 1.21 | 1.1 | 1.27 | 1.12 | 1.33 | 1.23 | 1.1 |
mitotic metaphase | 1 | -1.06 | 1.01 | -1.03 | 1.11 | -1.07 | -1.08 | -1.08 |
mitotic anaphase | 19 | 1.3 | 1.13 | 1.29 | 1.17 | 1.36 | 1.32 | 1.11 |
mitotic anaphase A | 4 | -1.13 | 1.29 | 1.25 | 1.15 | 1.37 | 1.13 | 1.24 |
mitotic anaphase B | 2 | 1.04 | 1.25 | 1.4 | 1.16 | 1.52 | -1.16 | 1.12 |
mitotic telophase | 1 | 1.4 | 1.02 | 1.15 | 1.14 | 1.72 | -1.18 | -1.16 |
sulfur amino acid metabolic process | 11 | 1.06 | -1.1 | -1.32 | 1.02 | -1.36 | 1.08 | -1.14 |
sulfur amino acid biosynthetic process | 3 | 1.32 | 1.11 | 1.04 | -1.09 | -1.92 | 1.19 | 1.3 |
sulfur amino acid catabolic process | 1 | 1.48 | 1.28 | 1.32 | 1.05 | 1.07 | 1.16 | -1.01 |
sulfur amino acid transmembrane transporter activity | 1 | -7.18 | -1.45 | -9.47 | 1.62 | 3.49 | -2.41 | -5.84 |
sulfur amino acid transport | 1 | -7.18 | -1.45 | -9.47 | 1.62 | 3.49 | -2.41 | -5.84 |
sulfate assimilation | 1 | -2.63 | 1.06 | 1.41 | 1.07 | 1.11 | -1.64 | -1.02 |
succinate dehydrogenase activity | 6 | 1.02 | 1.03 | 1.28 | -1.03 | -1.0 | 1.38 | -1.21 |
nucleotide-excision repair complex | 3 | 1.73 | 1.2 | 1.21 | 1.15 | 1.32 | 1.1 | -1.16 |
regulation of transcription involved in G2/M-phase of mitotic cell cycle | 1 | 1.12 | 1.4 | 1.69 | -1.0 | 1.67 | 1.7 | 1.71 |
histone deacetylase complex | 16 | 1.3 | 1.16 | 1.3 | 1.17 | 1.34 | 1.37 | 1.21 |
negative regulation of transcription from RNA polymerase II promoter | 104 | 1.12 | 1.05 | 1.08 | -1.01 | 1.16 | 1.18 | 1.11 |
histone acetyltransferase complex | 40 | 1.37 | 1.14 | 1.22 | 1.23 | 1.26 | 1.13 | 1.06 |
SAGA complex | 20 | 1.38 | 1.1 | 1.14 | 1.26 | 1.22 | 1.03 | -1.02 |
transcription factor TFIIIB complex | 2 | 1.19 | 1.29 | 1.5 | 1.13 | 1.51 | 1.31 | 1.18 |
establishment of mitotic spindle orientation | 2 | 1.02 | 1.4 | 1.82 | 1.21 | 1.49 | 1.4 | 1.34 |
Golgi cis cisterna | 1 | -1.12 | 1.19 | 1.36 | 1.12 | 1.23 | -1.28 | 1.74 |
Golgi trans cisterna | 2 | -1.03 | 1.16 | 1.1 | 1.38 | 1.81 | 1.12 | 1.1 |
Golgi membrane | 37 | 1.04 | 1.11 | 1.07 | 1.1 | 1.06 | 1.29 | 1.38 |
microfilament motor activity | 3 | 6.28 | -1.75 | 1.12 | -1.66 | 1.09 | 3.74 | -1.21 |
SNARE binding | 6 | -1.14 | 1.05 | 1.42 | 1.11 | 1.29 | 1.2 | 1.24 |
recombinase activity | 4 | 1.15 | 1.04 | -1.05 | 1.11 | 1.09 | -1.16 | -1.08 |
ubiquitin ligase complex | 43 | 1.31 | 1.15 | 1.31 | 1.16 | 1.28 | 1.18 | 1.18 |
nuclear ubiquitin ligase complex | 19 | 1.18 | 1.15 | 1.35 | 1.18 | 1.34 | 1.11 | 1.14 |
cytoplasmic ubiquitin ligase complex | 1 | 2.69 | 1.18 | 1.72 | 1.15 | -1.01 | -1.18 | -1.08 |
rRNA modification | 5 | 1.57 | 1.18 | 1.26 | 1.33 | 1.41 | 1.18 | -1.02 |
two-component sensor activity | 3 | 1.12 | -1.13 | 1.03 | -1.08 | 1.69 | 1.52 | -1.14 |
two-component response regulator activity | 1 | -1.1 | 1.39 | 1.36 | 1.05 | 1.38 | 3.53 | 1.68 |
protein phosphatase type 2A complex | 8 | 1.09 | 1.04 | 1.37 | 1.07 | 1.23 | 2.15 | 1.1 |
two-component signal transduction system (phosphorelay) | 3 | -1.1 | 1.14 | 1.08 | -1.02 | -1.02 | 1.53 | 1.01 |
protein phosphatase type 1 complex | 5 | 1.43 | 1.05 | 1.28 | 1.01 | 1.16 | 1.5 | 1.4 |
MAPK cascade | 35 | -1.01 | 1.14 | 1.46 | 1.09 | 1.46 | 1.19 | 1.31 |
nucleotide binding | 1153 | 1.12 | 1.07 | 1.11 | 1.06 | 1.16 | 1.16 | 1.09 |
ribonuclease MRP complex | 1 | 1.84 | 1.03 | 1.1 | 1.42 | 1.17 | 1.05 | -1.14 |
3'-5'-exoribonuclease activity | 15 | 1.46 | 1.13 | 1.16 | 1.27 | 1.25 | 1.2 | 1.04 |
nuclear exosome (RNase complex) | 13 | 1.3 | 1.17 | 1.14 | 1.29 | 1.27 | 1.13 | 1.05 |
cytoplasmic exosome (RNase complex) | 8 | 1.45 | 1.11 | 1.16 | 1.3 | 1.29 | 1.15 | -1.0 |
exosome (RNase complex) | 13 | 1.3 | 1.17 | 1.14 | 1.29 | 1.27 | 1.13 | 1.05 |
rRNA (adenine-N6,N6-)-dimethyltransferase activity | 2 | 1.61 | 1.27 | 1.44 | 1.22 | 1.57 | 1.46 | 1.13 |
cytosolic large ribosomal subunit | 50 | 1.38 | 1.02 | 1.09 | 1.0 | 1.14 | 1.2 | 1.09 |
cytosolic small ribosomal subunit | 33 | 1.37 | 1.02 | 1.1 | 1.02 | 1.14 | 1.17 | 1.04 |
rDNA binding | 2 | -1.04 | 1.15 | 1.82 | 1.29 | 2.02 | 1.26 | 1.15 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 12 | -1.19 | 1.17 | 1.13 | 1.22 | 1.25 | -1.02 | 1.0 |
activation of MAPKKK activity | 1 | -1.25 | 1.21 | 1.4 | 1.19 | 1.07 | 1.11 | 1.44 |
activation of MAPKK activity | 3 | 1.19 | 1.2 | 1.4 | 1.2 | 1.34 | 1.15 | 1.19 |
activation of MAPK activity | 7 | 1.11 | 1.21 | 1.54 | 1.12 | 1.37 | 2.0 | 1.14 |
inactivation of MAPK activity | 1 | 2.84 | 1.44 | 1.69 | 1.19 | 1.68 | 4.37 | 1.83 |
MAPK import into nucleus | 1 | 1.14 | 1.19 | 1.6 | 1.04 | 1.48 | 1.45 | 1.57 |
protein binding | 1244 | 1.17 | 1.05 | 1.21 | 1.04 | 1.22 | 1.2 | 1.14 |
modification-dependent protein catabolic process | 94 | 1.17 | 1.13 | 1.33 | 1.13 | 1.3 | 1.1 | 1.12 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 5 | 1.02 | 1.13 | 2.15 | 1.07 | 1.56 | 1.16 | 1.11 |
meiotic spindle organization | 22 | 1.17 | -1.06 | -1.01 | -1.07 | 1.19 | 1.02 | 1.17 |
tRNA-intron endonuclease activity | 1 | 1.37 | 1.2 | -1.07 | 1.24 | 1.11 | -1.16 | -1.02 |
tRNA-intron endonuclease complex | 1 | 1.37 | 1.2 | -1.07 | 1.24 | 1.11 | -1.16 | -1.02 |
DNA secondary structure binding | 3 | -1.08 | 1.33 | 1.37 | 1.18 | 1.48 | -1.09 | 1.25 |
proton-transporting two-sector ATPase complex | 48 | -1.18 | 1.0 | 1.27 | -1.11 | -1.06 | 1.39 | -1.15 |
vacuolar proton-transporting V-type ATPase, V0 domain | 13 | -2.32 | -1.03 | 1.35 | -1.29 | -1.38 | 1.02 | -1.29 |
vacuolar proton-transporting V-type ATPase, V1 domain | 12 | -1.17 | 1.02 | 1.44 | -1.12 | -1.04 | 1.8 | -1.01 |
peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity | 1 | -1.09 | 1.27 | 1.39 | 1.28 | 1.54 | -1.1 | 1.18 |
microtubule cytoskeleton organization | 338 | 1.13 | 1.1 | 1.24 | 1.09 | 1.26 | 1.18 | 1.09 |
nuclear chromosome | 88 | 1.19 | 1.12 | 1.23 | 1.14 | 1.27 | 1.13 | 1.03 |
cytoplasmic chromosome | 1 | 1.18 | 1.16 | 1.75 | 1.38 | 1.68 | 1.06 | -1.24 |
condensed nuclear chromosome | 15 | 1.25 | 1.06 | 1.23 | 1.06 | 1.25 | 1.24 | 1.09 |
condensed chromosome | 38 | 1.15 | 1.06 | 1.23 | 1.09 | 1.3 | 1.2 | 1.07 |
mitotic prometaphase | 1 | -1.39 | -1.16 | -1.07 | 1.34 | 1.62 | -1.16 | -1.17 |
pericentriolar material | 6 | 1.07 | 1.05 | 1.08 | 1.04 | 1.14 | 1.08 | 1.03 |
spliceosomal complex assembly | 14 | 1.26 | 1.11 | 1.27 | 1.23 | 1.28 | 1.21 | -1.02 |
C-4 methylsterol oxidase activity | 2 | -1.31 | -6.89 | -7.44 | -1.07 | -3.2 | -1.65 | -1.68 |
allantoin metabolic process | 2 | 3.32 | -1.45 | -1.35 | -1.39 | -1.17 | 1.29 | -1.34 |
allantoin catabolic process | 1 | 2.85 | -1.01 | 1.16 | 1.03 | -1.08 | 1.74 | -1.1 |
nitrilase activity | 2 | 1.33 | 1.42 | -1.12 | 1.25 | 1.47 | 1.28 | -1.05 |
sodium:amino acid symporter activity | 5 | 1.26 | 1.14 | -2.06 | -1.96 | -1.76 | -1.26 | 1.36 |
nucleoside transmembrane transporter activity | 6 | -1.51 | 1.3 | -1.37 | 1.14 | -1.09 | -1.36 | -1.05 |
intracellular | 4036 | 1.14 | 1.07 | 1.15 | 1.08 | 1.18 | 1.16 | 1.05 |
proton-transporting ATPase activity, rotational mechanism | 21 | 1.15 | -1.01 | 1.22 | -1.1 | -1.03 | 1.64 | -1.08 |
mitochondrial chromosome | 1 | 1.18 | 1.16 | 1.75 | 1.38 | 1.68 | 1.06 | -1.24 |
GTPase activity | 136 | 1.2 | 1.08 | 1.29 | 1.07 | 1.22 | 1.09 | 1.05 |
heterotrimeric G-protein complex | 18 | 1.39 | 1.11 | 1.42 | 1.06 | 1.22 | 1.03 | 1.1 |
mitochondrial fission | 2 | 1.47 | -1.03 | 1.65 | 1.15 | 1.07 | 1.58 | -1.11 |
cell fraction | 106 | -1.02 | -1.12 | -1.21 | -1.02 | 1.06 | -1.09 | -1.04 |
peroxisome targeting sequence binding | 3 | 1.2 | -1.04 | -1.07 | 1.13 | 1.12 | -1.21 | -1.06 |
peptidoglycan metabolic process | 12 | -1.13 | -1.64 | -1.19 | -1.04 | -1.82 | -1.69 | -1.29 |
polysaccharide biosynthetic process | 22 | 1.55 | 1.02 | -1.01 | 1.03 | 1.12 | 1.58 | 1.25 |
polysaccharide catabolic process | 30 | -1.17 | -1.91 | -2.09 | -1.67 | -1.68 | -1.04 | 1.4 |
mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) | 8 | 1.58 | -1.08 | 1.12 | -1.1 | 1.01 | 1.92 | -1.31 |
mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) | 9 | 1.19 | 1.04 | 1.31 | 1.01 | 1.22 | 1.62 | -1.14 |
mitotic cell cycle | 399 | 1.21 | 1.11 | 1.24 | 1.12 | 1.29 | 1.21 | 1.1 |
nuclear division | 149 | 1.23 | 1.09 | 1.27 | 1.11 | 1.32 | 1.26 | 1.12 |
cytokinesis after mitosis | 5 | -1.12 | 1.17 | 1.26 | 1.17 | 1.24 | -1.37 | 1.01 |
1-phosphatidylinositol-3-phosphate 5-kinase activity | 1 | -1.33 | 1.29 | 1.91 | 1.33 | 2.36 | 1.28 | 1.16 |
magnesium ion binding | 46 | 1.08 | 1.06 | 1.18 | 1.05 | 1.15 | 1.38 | 1.01 |
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 10 | 1.48 | 1.17 | 1.74 | 1.19 | 1.61 | 1.9 | 1.56 |
nuclear-transcribed mRNA poly(A) tail shortening | 7 | 1.62 | 1.13 | 1.74 | 1.15 | 1.59 | 2.05 | 1.42 |
deadenylation-dependent decapping of nuclear-transcribed mRNA | 2 | 1.27 | 1.29 | 1.78 | 1.53 | 1.51 | 1.59 | 1.46 |
nuclear-transcribed mRNA catabolic process, exonucleolytic | 1 | -1.45 | 1.76 | 1.14 | 1.42 | 1.29 | -1.3 | 1.32 |
integral to membrane of membrane fraction | 2 | 1.74 | 1.04 | 1.6 | 1.07 | 1.43 | 2.77 | 1.46 |
peripheral to membrane of membrane fraction | 2 | -1.06 | 1.15 | 1.33 | 1.33 | 1.33 | 1.07 | -1.07 |
retrograde transport, vesicle recycling within Golgi | 10 | -1.16 | 1.12 | 1.17 | 1.04 | 1.21 | 1.41 | 1.65 |
response to reactive oxygen species | 16 | 1.05 | 1.06 | 1.08 | 1.15 | 1.2 | -1.01 | -1.15 |
response to superoxide | 2 | 1.69 | 1.17 | 1.01 | 1.09 | 1.11 | 1.41 | -1.08 |
response to oxygen radical | 2 | 1.69 | 1.17 | 1.01 | 1.09 | 1.11 | 1.41 | -1.08 |
cyclin-dependent protein kinase holoenzyme complex | 7 | 1.06 | 1.09 | 1.22 | 1.21 | 1.41 | -1.23 | -1.12 |
nicotinamide-nucleotide adenylyltransferase activity | 1 | -2.52 | 1.99 | 1.32 | 1.32 | 1.09 | -1.34 | 1.43 |
organellar ribosome | 72 | 1.04 | 1.07 | 1.23 | 1.29 | 1.25 | 1.45 | -1.55 |
organellar small ribosomal subunit | 30 | 1.04 | 1.09 | 1.24 | 1.27 | 1.23 | 1.47 | -1.48 |
organellar large ribosomal subunit | 44 | 1.03 | 1.05 | 1.24 | 1.3 | 1.28 | 1.46 | -1.6 |
protein-methionine-R-oxide reductase activity | 1 | 2.04 | 1.02 | -1.15 | -1.19 | -1.3 | 1.08 | -1.25 |
lytic vacuole | 28 | -2.58 | -1.1 | -2.35 | 1.15 | -1.08 | -2.06 | -3.03 |
negative regulation of transposition, DNA-mediated | 1 | -1.25 | 1.2 | 1.21 | 1.19 | 1.06 | -1.14 | 1.03 |
regulation of transposition, DNA-mediated | 1 | -1.25 | 1.2 | 1.21 | 1.19 | 1.06 | -1.14 | 1.03 |
RNA cap binding | 13 | 1.12 | 1.12 | 1.2 | 1.04 | 1.14 | 1.12 | 1.32 |
RNA 7-methylguanosine cap binding | 9 | 1.06 | 1.12 | 1.24 | -1.0 | 1.11 | 1.11 | 1.44 |
THO complex | 5 | 1.18 | 1.1 | 1.39 | 1.17 | 1.27 | 1.37 | 1.09 |
RNA splicing, via transesterification reactions | 180 | 1.17 | 1.11 | 1.21 | 1.23 | 1.31 | 1.16 | 1.0 |
RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 177 | 1.17 | 1.11 | 1.21 | 1.23 | 1.31 | 1.15 | 1.0 |
alternative nuclear mRNA splicing, via spliceosome | 1 | 1.52 | 1.27 | 1.61 | 1.3 | 1.51 | 2.77 | 1.58 |
regulation of alternative nuclear mRNA splicing, via spliceosome | 52 | 1.22 | 1.17 | 1.28 | 1.16 | 1.24 | 1.42 | 1.09 |
spliceosomal snRNP assembly | 1 | 1.14 | -1.01 | 1.12 | 1.41 | 1.03 | -1.2 | -1.43 |
spliceosomal complex disassembly | 1 | 1.69 | 1.29 | 1.56 | 1.32 | 1.6 | 1.63 | 1.44 |
RNA splicing, via endonucleolytic cleavage and ligation | 3 | 1.93 | 1.15 | 1.42 | 1.2 | 1.36 | 1.44 | 1.34 |
nuclear mRNA splicing, via spliceosome | 177 | 1.17 | 1.11 | 1.21 | 1.23 | 1.31 | 1.15 | 1.0 |
four-way junction DNA binding | 1 | -1.12 | 1.35 | 2.36 | 1.33 | 2.9 | 1.28 | 1.43 |
Y-form DNA binding | 1 | 1.11 | 1.31 | -1.06 | 1.14 | -1.02 | -1.04 | 1.09 |
mitochondrion degradation | 1 | 2.65 | 1.08 | 1.15 | 1.38 | 1.25 | 2.74 | 1.17 |
DNA-directed RNA polymerase complex | 23 | 1.32 | 1.14 | 1.23 | 1.25 | 1.26 | 1.12 | 1.07 |
core TFIIH complex | 4 | 1.37 | 1.09 | 1.37 | 1.35 | 1.33 | 1.15 | 1.06 |
SSL2-core TFIIH complex | 4 | 1.37 | 1.09 | 1.37 | 1.35 | 1.33 | 1.15 | 1.06 |
maturation of 2S rRNA | 1 | 1.7 | -1.05 | -1.07 | -1.09 | -1.18 | 1.33 | 1.14 |
base pairing | 2 | 1.38 | 1.09 | 1.14 | 1.35 | 1.29 | -1.02 | -1.04 |
base pairing with RNA | 2 | 1.38 | 1.09 | 1.14 | 1.35 | 1.29 | -1.02 | -1.04 |
proteasome complex | 55 | 1.37 | 1.04 | 1.2 | 1.15 | 1.17 | -1.02 | 1.02 |
embryonic axis specification | 118 | 1.23 | 1.09 | 1.29 | 1.05 | 1.24 | 1.31 | 1.25 |
mismatch base pair DNA N-glycosylase activity | 1 | -1.08 | 1.06 | -1.04 | 1.0 | -1.17 | 1.06 | -1.14 |
oxidized base lesion DNA N-glycosylase activity | 3 | 2.16 | -1.01 | 1.16 | 1.13 | 1.13 | 1.51 | -1.03 |
oxidized pyrimidine base lesion DNA N-glycosylase activity | 1 | 3.75 | 1.0 | 1.19 | 1.14 | 1.11 | 1.95 | 1.06 |
achiasmate meiosis I | 1 | -1.17 | 1.02 | -1.13 | 1.11 | -1.02 | -1.2 | -1.13 |
meiotic DNA recombinase assembly | 1 | -1.21 | 1.44 | 1.1 | 1.2 | 1.03 | -1.18 | 1.17 |
meiotic mismatch repair | 1 | 1.34 | 1.15 | 1.36 | 1.37 | 1.61 | 1.16 | 1.18 |
resolution of meiotic recombination intermediates | 4 | 1.0 | 1.09 | 1.25 | 1.17 | 1.45 | 1.14 | 1.06 |
nucleotide-excision repair, DNA damage recognition | 1 | 1.35 | 1.22 | 1.6 | 1.15 | 1.67 | 2.6 | 1.56 |
telomere maintenance | 14 | 1.19 | 1.12 | 1.39 | 1.17 | 1.35 | 1.2 | 1.11 |
double-strand break repair via homologous recombination | 7 | 1.12 | 1.16 | 1.16 | 1.17 | 1.22 | -1.03 | 1.11 |
recombinational repair | 7 | 1.12 | 1.16 | 1.16 | 1.17 | 1.22 | -1.03 | 1.11 |
non-recombinational repair | 6 | -1.06 | 1.22 | 1.37 | 1.12 | 1.33 | -1.11 | 1.14 |
DNA recombinase assembly | 1 | -1.21 | 1.44 | 1.1 | 1.2 | 1.03 | -1.18 | 1.17 |
DNA synthesis involved in DNA repair | 1 | 1.11 | 1.31 | -1.06 | 1.14 | -1.02 | -1.04 | 1.09 |
strand displacement | 1 | 1.11 | 1.31 | -1.06 | 1.14 | -1.02 | -1.04 | 1.09 |
DNA catabolic process, endonucleolytic | 4 | 1.64 | 1.12 | 1.39 | 1.15 | 1.35 | 1.4 | 1.54 |
DNA catabolic process, exonucleolytic | 2 | -1.31 | 1.21 | 1.11 | 1.22 | 1.62 | -1.59 | -1.29 |
DNA strand annealing activity | 2 | 1.04 | 1.17 | 1.07 | 1.09 | 1.08 | 1.05 | 1.03 |
karyogamy | 6 | 1.05 | 1.11 | 1.23 | 1.09 | 1.44 | 1.02 | 1.13 |
syncytium formation by plasma membrane fusion | 27 | 1.01 | 1.06 | 1.27 | -1.02 | 1.21 | 1.27 | 1.14 |
adenyl-nucleotide exchange factor activity | 1 | -1.14 | 1.21 | -1.05 | 1.17 | 1.0 | -1.29 | -1.36 |
chromosome, centromeric region | 54 | 1.2 | 1.07 | 1.19 | 1.11 | 1.31 | 1.15 | 1.07 |
kinetochore | 31 | 1.18 | 1.08 | 1.16 | 1.14 | 1.33 | 1.13 | -1.0 |
condensed chromosome kinetochore | 9 | 1.03 | 1.06 | 1.14 | 1.12 | 1.28 | -1.06 | -1.03 |
condensed nuclear chromosome kinetochore | 1 | 1.0 | 1.07 | -1.07 | 1.19 | -1.13 | -1.28 | 1.01 |
condensed chromosome, centromeric region | 13 | 1.09 | 1.06 | 1.24 | 1.12 | 1.37 | 1.11 | 1.02 |
condensed nuclear chromosome, centromeric region | 7 | 1.24 | 1.07 | 1.34 | 1.12 | 1.41 | 1.38 | 1.12 |
chromosome, telomeric region | 10 | 1.35 | 1.09 | 1.3 | 1.17 | 1.42 | 1.18 | 1.05 |
nuclear chromosome, telomeric region | 2 | 1.89 | 1.01 | 1.39 | 1.11 | 1.79 | 1.05 | 1.11 |
chromatin | 122 | 1.11 | 1.12 | 1.24 | 1.14 | 1.27 | 1.15 | 1.12 |
nucleosome | 15 | -1.1 | 1.01 | 1.25 | 1.15 | 1.09 | -1.35 | -1.01 |
nuclear nucleosome | 1 | 1.0 | 1.07 | -1.07 | 1.19 | -1.13 | -1.28 | 1.01 |
nuclear chromatin | 49 | 1.15 | 1.15 | 1.25 | 1.15 | 1.27 | 1.14 | 1.09 |
euchromatin | 12 | 1.14 | 1.22 | 1.34 | 1.18 | 1.46 | 1.33 | 1.26 |
heterochromatin | 22 | 1.14 | 1.16 | 1.29 | 1.08 | 1.32 | 1.36 | 1.33 |
synaptonemal complex | 4 | 1.04 | 1.05 | 1.03 | 1.0 | -1.02 | -1.06 | 1.06 |
condensin complex | 8 | 1.13 | 1.05 | 1.18 | 1.06 | 1.26 | 1.27 | 1.12 |
sex chromosome | 7 | 1.3 | 1.17 | 1.32 | 1.09 | 1.18 | 1.39 | 1.28 |
X chromosome | 6 | 1.37 | 1.23 | 1.41 | 1.11 | 1.23 | 1.51 | 1.37 |
Y chromosome | 1 | -1.03 | -1.14 | -1.12 | -1.01 | -1.12 | -1.2 | -1.19 |
origin recognition complex | 7 | 1.06 | 1.15 | 1.09 | 1.19 | 1.24 | 1.01 | -1.08 |
GINS complex | 2 | 1.77 | 1.11 | 1.3 | 1.14 | 1.18 | 1.14 | -1.06 |
sister chromatid segregation | 56 | 1.25 | 1.07 | 1.3 | 1.11 | 1.37 | 1.27 | 1.09 |
inositol-1,4,5-trisphosphate 6-kinase activity | 1 | -1.15 | 1.56 | -1.07 | 1.07 | -1.15 | -1.25 | 1.09 |
inositol hexakisphosphate kinase activity | 1 | -1.38 | 1.16 | 2.02 | -1.07 | 2.12 | 1.33 | 1.59 |
translation repressor activity, nucleic acid binding | 6 | 1.94 | 1.04 | 2.03 | 1.04 | 1.61 | 1.46 | 1.82 |
cell morphogenesis involved in differentiation | 351 | 1.14 | 1.09 | 1.26 | 1.04 | 1.28 | 1.28 | 1.26 |
cytokinesis | 81 | 1.03 | 1.07 | 1.23 | 1.06 | 1.32 | 1.09 | 1.11 |
assembly of actomyosin apparatus involved in cell cycle cytokinesis | 14 | 1.26 | -1.24 | -1.03 | -1.27 | 1.08 | 1.13 | 1.08 |
cytokinesis, actomyosin contractile ring assembly | 14 | 1.26 | -1.24 | -1.03 | -1.27 | 1.08 | 1.13 | 1.08 |
contractile ring contraction involved in cell cycle cytokinesis | 7 | 1.0 | 1.24 | 1.32 | 1.18 | 1.42 | 1.29 | 1.17 |
cytokinetic cell separation | 1 | -1.24 | -1.05 | 1.11 | 1.18 | 1.4 | -1.36 | -1.18 |
spindle pole | 23 | 1.28 | 1.12 | 1.43 | 1.06 | 1.39 | 1.41 | 1.26 |
gamma-tubulin complex | 8 | 1.55 | 1.01 | 1.26 | 1.07 | 1.31 | 1.48 | 1.15 |
gamma-tubulin large complex | 5 | 1.67 | -1.04 | 1.23 | 1.09 | 1.31 | 1.41 | 1.1 |
cytoplasmic mRNA processing body | 13 | 1.31 | 1.27 | 1.6 | 1.18 | 1.51 | 1.59 | 1.3 |
condensed chromosome inner kinetochore | 1 | 1.0 | 1.07 | -1.07 | 1.19 | -1.13 | -1.28 | 1.01 |
condensed chromosome outer kinetochore | 7 | -1.03 | 1.07 | 1.16 | 1.1 | 1.38 | -1.08 | -1.04 |
condensed nuclear chromosome inner kinetochore | 1 | 1.0 | 1.07 | -1.07 | 1.19 | -1.13 | -1.28 | 1.01 |
base pairing with rRNA | 2 | 1.38 | 1.09 | 1.14 | 1.35 | 1.29 | -1.02 | -1.04 |
nuclear-transcribed mRNA catabolic process | 23 | 1.11 | 1.16 | 1.34 | 1.18 | 1.37 | 1.32 | 1.21 |
mitochondrial RNA metabolic process | 3 | 1.29 | 1.23 | 1.41 | 1.12 | 1.47 | 1.73 | -1.1 |
regulatory region DNA binding | 74 | 1.02 | 1.03 | 1.06 | 1.02 | 1.11 | 1.13 | 1.07 |
transcription regulatory region sequence-specific DNA binding | 65 | 1.03 | 1.01 | 1.06 | 1.01 | 1.09 | 1.15 | 1.08 |
RNA polymerase II regulatory region sequence-specific DNA binding | 45 | 1.09 | -1.0 | 1.06 | 1.02 | 1.1 | 1.12 | 1.05 |
RNA polymerase II core promoter proximal region sequence-specific DNA binding | 4 | 1.25 | 1.09 | 1.19 | 1.0 | 1.33 | 1.57 | 1.45 |
RNA polymerase II distal enhancer sequence-specific DNA binding | 17 | 1.22 | 1.05 | 1.08 | -1.03 | 1.01 | 1.06 | 1.21 |
sequence-specific DNA binding RNA polymerase II transcription factor activity | 150 | 1.13 | 1.02 | 1.1 | -1.01 | 1.12 | 1.15 | 1.16 |
RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity | 59 | 1.12 | 1.09 | 1.16 | 1.01 | 1.21 | 1.12 | 1.21 |
RNA polymerase II core promoter sequence-specific DNA binding transcription factor activity | 19 | 1.4 | 1.13 | 1.24 | 1.2 | 1.34 | 1.2 | 1.07 |
core promoter proximal region sequence-specific DNA binding | 5 | 1.34 | 1.15 | 1.24 | 1.06 | 1.3 | 1.49 | 1.32 |
protein binding transcription factor activity | 95 | 1.28 | 1.11 | 1.27 | 1.15 | 1.34 | 1.24 | 1.16 |
transcription factor binding transcription factor activity | 95 | 1.28 | 1.11 | 1.27 | 1.15 | 1.34 | 1.24 | 1.16 |
RNA polymerase II regulatory region DNA binding | 47 | 1.09 | 1.0 | 1.06 | 1.02 | 1.1 | 1.12 | 1.04 |
core promoter sequence-specific DNA binding | 2 | -1.01 | 1.32 | 1.26 | 1.21 | 1.46 | 1.11 | 1.06 |
core promoter binding | 2 | -1.01 | 1.32 | 1.26 | 1.21 | 1.46 | 1.11 | 1.06 |
regulatory region nucleic acid binding | 74 | 1.02 | 1.03 | 1.06 | 1.02 | 1.11 | 1.13 | 1.07 |
nucleic acid binding transcription factor activity | 411 | 1.09 | 1.04 | 1.09 | 1.01 | 1.1 | 1.11 | 1.09 |
sequence-specific core promoter binding RNA polymerase II transcription factor activity involved in preinitiation complex assembly | 18 | 1.41 | 1.13 | 1.25 | 1.21 | 1.36 | 1.2 | 1.08 |
RNA polymerase II transcription factor binding transcription factor activity | 46 | 1.44 | 1.04 | 1.23 | 1.18 | 1.35 | 1.26 | 1.1 |
RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 40 | 1.12 | 1.13 | 1.2 | 1.01 | 1.21 | 1.17 | 1.23 |
RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription | 21 | 1.21 | 1.02 | 1.09 | 1.02 | 1.19 | 1.01 | 1.17 |
RNA polymerase II basal transcription factor binding transcription factor activity | 6 | 1.58 | 1.1 | 1.46 | 1.16 | 1.41 | 1.29 | 1.2 |
RNA polymerase II transcription factor binding | 15 | 1.46 | -1.02 | 1.01 | 1.1 | 1.19 | 1.25 | 1.17 |
RNA polymerase II basal transcription factor binding | 7 | 1.26 | 1.21 | 1.29 | 1.22 | 1.32 | 1.14 | 1.2 |
TFIIA-class transcription factor binding | 3 | 1.34 | 1.29 | 1.39 | 1.2 | 1.61 | 1.37 | 1.28 |
TFIIB-class transcription factor binding | 1 | 1.15 | 1.32 | 1.1 | 1.22 | 1.43 | 1.06 | 1.02 |
TFIID-class transcription factor binding | 2 | 1.34 | 1.01 | -1.02 | 1.28 | 1.04 | -1.14 | -1.12 |
TFIIF-class transcription factor binding | 2 | 1.1 | 1.32 | 1.52 | 1.2 | 1.24 | 1.14 | 1.45 |
basal transcription machinery binding | 8 | 1.09 | 1.07 | 1.15 | 1.14 | 1.23 | 1.02 | 1.08 |
basal RNA polymerase II transcription machinery binding | 8 | 1.09 | 1.07 | 1.15 | 1.14 | 1.23 | 1.02 | 1.08 |
response to acid | 5 | 1.44 | -1.04 | 1.24 | 1.2 | 1.26 | 1.13 | -1.15 |
RNA polymerase II activating transcription factor binding | 4 | 2.11 | -1.73 | -1.85 | -1.26 | -1.03 | 1.44 | 1.34 |
RNA polymerase II repressing transcription factor binding | 2 | 1.24 | 1.19 | 1.36 | 1.24 | 1.29 | 1.42 | 1.1 |
RNA polymerase II transcription cofactor activity | 41 | 1.42 | 1.04 | 1.22 | 1.19 | 1.34 | 1.27 | 1.09 |
RNA polymerase II transcription coactivator activity | 8 | 1.57 | -1.19 | -1.01 | 1.03 | 1.27 | 1.49 | 1.13 |
RNA polymerase II transcription corepressor activity | 2 | 1.12 | 1.2 | 1.26 | 1.29 | 1.7 | 1.19 | 1.25 |
promoter clearance during DNA-dependent transcription | 5 | 1.21 | 1.11 | 1.42 | 1.33 | 1.33 | 1.15 | 1.09 |
promoter clearance from RNA polymerase II promoter | 5 | 1.21 | 1.11 | 1.42 | 1.33 | 1.33 | 1.15 | 1.09 |
DNA-dependent transcriptional open complex formation | 5 | 1.21 | 1.11 | 1.42 | 1.33 | 1.33 | 1.15 | 1.09 |
transcriptional open complex formation at RNA polymerase II promoter | 5 | 1.21 | 1.11 | 1.42 | 1.33 | 1.33 | 1.15 | 1.09 |
protein-DNA complex remodeling | 5 | 1.21 | 1.11 | 1.42 | 1.33 | 1.33 | 1.15 | 1.09 |
RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly | 2 | 1.66 | -1.04 | 1.36 | 1.21 | 1.19 | 1.16 | -1.0 |
TBP-class protein binding RNA polymerase II transcription factor activity involved in preinitiation complex assembly | 6 | 1.58 | 1.1 | 1.46 | 1.16 | 1.41 | 1.29 | 1.2 |
TBP-class protein binding RNA polymerase II transcription factor activity | 6 | 1.58 | 1.1 | 1.46 | 1.16 | 1.41 | 1.29 | 1.2 |
enhancer sequence-specific DNA binding | 18 | 1.2 | 1.05 | 1.07 | -1.02 | 1.0 | 1.04 | 1.19 |
core promoter proximal region DNA binding | 5 | 1.34 | 1.15 | 1.24 | 1.06 | 1.3 | 1.49 | 1.32 |
DNA-dependent transcriptional start site selection | 1 | 2.19 | 1.23 | -1.08 | 1.33 | 1.17 | -1.1 | 1.1 |
transcriptional start site selection at RNA polymerase II promoter | 1 | 2.19 | 1.23 | -1.08 | 1.33 | 1.17 | -1.1 | 1.1 |
RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription | 8 | 1.57 | -1.19 | -1.01 | 1.03 | 1.27 | 1.49 | 1.13 |
RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription | 3 | 1.37 | 1.05 | 1.07 | 1.1 | 1.48 | -1.12 | 1.13 |
age-dependent response to oxidative stress | 1 | -1.1 | 1.09 | 1.19 | 1.01 | 1.01 | 1.19 | 1.25 |
entry into host | 2 | 1.04 | 1.05 | 1.19 | -1.29 | -1.39 | 2.64 | 1.17 |
neurotransmitter uptake | 1 | -1.06 | -1.11 | -1.0 | -1.08 | -1.15 | 3.37 | -1.04 |
regulation of neurotransmitter levels | 106 | -1.07 | 1.06 | 1.19 | 1.11 | 1.22 | 1.06 | 1.07 |
neurotransmitter biosynthetic process | 4 | 1.15 | -1.01 | -1.13 | -1.06 | 1.01 | -1.12 | -1.05 |
acetylcholine catabolic process in synaptic cleft | 1 | 2.27 | 1.23 | -5.17 | -1.59 | -2.2 | -9.9 | 9.42 |
regulation of action potential | 8 | 1.57 | -1.04 | 1.3 | -1.12 | 1.17 | 2.65 | 1.29 |
cysteine-type endopeptidase activity | 29 | -1.39 | -1.19 | 1.01 | -1.08 | 1.27 | -1.29 | -1.2 |
RNA methylation | 10 | 1.62 | 1.18 | 1.23 | 1.26 | 1.35 | 1.29 | 1.02 |
microfibril | 1 | 1.02 | -1.0 | 1.14 | 1.18 | 1.1 | 1.03 | -1.08 |
calcium ion binding | 192 | 1.36 | -1.02 | 1.1 | -1.05 | 1.09 | 1.28 | 1.2 |
selenocysteine incorporation | 1 | 1.74 | 1.02 | 1.02 | 1.41 | 1.48 | -1.49 | -1.06 |
voltage-gated sodium channel complex | 1 | 1.49 | 1.1 | 1.18 | 1.37 | 1.22 | 1.19 | 1.04 |
peptide amidation | 1 | 2.74 | 1.3 | 1.75 | 1.08 | 1.98 | 1.97 | 2.28 |
pseudouridine synthesis | 12 | 1.48 | 1.3 | 1.18 | 1.15 | 1.18 | 1.37 | 1.11 |
retinoid metabolic process | 3 | 1.01 | -1.01 | 1.02 | 1.05 | -1.08 | 1.07 | -1.1 |
oxygen transporter activity | 11 | 1.36 | 1.04 | 1.04 | -1.04 | -1.15 | 1.01 | -1.01 |
proteoglycan metabolic process | 18 | 1.24 | 1.14 | 1.2 | 1.07 | 1.15 | 1.23 | 1.5 |
sulfur compound metabolic process | 37 | -1.0 | 1.04 | 1.02 | 1.1 | 1.02 | 1.18 | 1.06 |
lipopolysaccharide binding | 1 | 8.83 | -1.7 | -1.73 | -1.63 | -1.34 | 3.89 | 1.3 |
ciliary or flagellar motility | 2 | 1.0 | -1.02 | -1.01 | -1.04 | -1.08 | -1.04 | 1.1 |
beta-amyloid binding | 1 | -1.11 | 1.12 | -1.05 | 1.06 | -1.09 | -1.06 | -1.01 |
ovarian follicle development | 1 | -1.49 | 2.58 | -1.26 | -1.23 | -1.23 | -1.38 | 1.24 |
oocyte growth | 2 | 1.25 | 1.36 | 1.54 | 1.22 | 1.6 | 1.07 | 1.72 |
oocyte maturation | 3 | -1.0 | 1.13 | -1.07 | -1.01 | -1.03 | -1.0 | 1.1 |
metabolic process | 3907 | -1.04 | -1.03 | -1.04 | 1.02 | 1.06 | -1.04 | -1.05 |
cell growth | 59 | 1.22 | 1.13 | 1.38 | 1.04 | 1.43 | 1.35 | 1.28 |
regulation of cell growth | 38 | 1.09 | 1.19 | 1.46 | 1.1 | 1.43 | 1.53 | 1.25 |
heterophilic cell-cell adhesion | 12 | -1.44 | 1.04 | 1.3 | -1.02 | 1.46 | -1.24 | 1.32 |
galactoside binding | 2 | 1.45 | -1.07 | 1.88 | 1.03 | 1.06 | 1.31 | 1.14 |
microtubule bundle formation | 16 | -1.31 | 1.1 | 1.24 | 1.11 | 1.2 | -1.29 | -1.07 |
detection of chemical stimulus involved in sensory perception of bitter taste | 1 | -1.77 | -1.51 | -1.46 | -1.66 | 9.03 | 1.38 | -1.43 |
detection of chemical stimulus involved in sensory perception of sweet taste | 1 | 15.43 | 1.05 | -1.1 | -1.34 | 2.06 | 11.73 | 3.15 |
Gi/o-coupled serotonin receptor activity | 1 | 1.44 | 1.03 | -1.0 | 1.12 | 1.06 | 1.16 | -1.02 |
Gq/11-coupled serotonin receptor activity | 1 | 1.13 | -1.11 | -1.04 | -1.12 | -1.18 | 1.14 | 1.05 |
dopamine receptor activity, coupled via Gs | 2 | -1.21 | 1.11 | -1.21 | 1.0 | -1.21 | -1.22 | -1.28 |
dopamine receptor activity, coupled via Gi/Go | 1 | -1.08 | -1.06 | -1.29 | 1.12 | -1.04 | -1.27 | -1.07 |
neuromedin U receptor activity | 1 | -1.22 | -1.11 | -1.12 | -1.18 | -1.25 | -1.3 | -1.2 |
G-protein coupled adenosine receptor activity | 1 | -1.32 | 1.16 | 1.21 | -1.14 | -1.21 | 1.47 | 1.08 |
dense fibrillar component | 1 | -1.19 | 1.16 | -1.05 | 1.68 | 1.27 | -1.6 | -1.28 |
peptide receptor activity | 45 | 1.11 | -1.06 | 1.03 | -1.06 | -1.05 | 1.15 | 1.01 |
eye development | 265 | 1.14 | 1.1 | 1.26 | 1.06 | 1.27 | 1.23 | 1.24 |
urogenital system development | 69 | 1.2 | -1.03 | 1.12 | -1.01 | 1.21 | 1.35 | 1.08 |
conditioned taste aversion | 3 | 1.58 | 1.48 | 1.62 | -1.13 | 1.26 | 1.28 | 1.57 |
G-protein coupled receptor binding | 7 | -1.1 | -1.01 | 1.12 | -1.08 | 1.17 | 1.16 | 1.2 |
response to hypoxia | 43 | 1.14 | 1.14 | 1.22 | 1.08 | 1.27 | 1.28 | 1.2 |
ameboidal cell migration | 35 | 1.62 | -1.01 | 1.31 | -1.06 | 1.21 | 1.46 | 1.11 |
acrosomal vesicle | 1 | -1.22 | 1.14 | 1.06 | 1.01 | -1.52 | -1.37 | 1.04 |
ATPase activator activity | 3 | 1.77 | 1.07 | 1.2 | 1.24 | 1.37 | 1.32 | 1.35 |
regulation of chromatin assembly or disassembly | 6 | 1.1 | 1.2 | 1.31 | 1.12 | 1.3 | 1.19 | 1.21 |
male germ cell nucleus | 10 | -1.1 | 1.13 | 1.01 | 1.03 | -1.05 | -1.24 | 1.05 |
female germ cell nucleus | 1 | 1.04 | 1.22 | 1.16 | 1.15 | 1.04 | -1.0 | -1.09 |
long-chain fatty acid metabolic process | 8 | 2.31 | -2.32 | -1.73 | -1.98 | -1.14 | -1.49 | 1.69 |
formation of translation initiation ternary complex | 1 | 1.02 | 1.21 | 1.26 | 1.24 | 1.31 | 1.17 | 1.22 |
tRNA 5'-leader removal | 1 | -1.05 | 1.03 | -1.13 | -1.0 | -1.0 | -1.23 | -1.11 |
axonemal dynein complex | 12 | -1.02 | 1.03 | 1.04 | 1.02 | -1.05 | 1.0 | -1.11 |
cytoplasmic dynein complex | 11 | -1.01 | 1.07 | 1.14 | 1.01 | 1.06 | 1.15 | -1.02 |
histamine metabolic process | 2 | 1.02 | -1.27 | 1.33 | 1.09 | 1.3 | 1.8 | 1.14 |
histamine biosynthetic process | 1 | -1.31 | -1.76 | 1.72 | 1.22 | 1.97 | 3.11 | 1.28 |
embryonic development via the syncytial blastoderm | 159 | 1.1 | 1.06 | 1.3 | 1.03 | 1.34 | 1.33 | 1.22 |
gastrulation with mouth forming first | 30 | 1.11 | -1.0 | 1.2 | 1.03 | 1.32 | 1.16 | 1.06 |
formation of primary germ layer | 28 | 1.53 | -1.01 | 1.18 | -1.09 | 1.11 | 1.67 | 1.15 |
ectoderm formation | 2 | 4.98 | -1.19 | 1.75 | -1.46 | 1.16 | 1.31 | 1.35 |
endoderm formation | 4 | 2.13 | -1.15 | 1.08 | -1.19 | 1.07 | 2.11 | 1.76 |
mesoderm formation | 26 | 1.41 | 1.01 | 1.15 | -1.07 | 1.1 | 1.6 | 1.11 |
cell fate specification | 59 | 1.11 | 1.06 | 1.1 | 1.04 | 1.17 | -1.02 | 1.22 |
cell fate determination | 122 | 1.2 | 1.07 | 1.23 | 1.02 | 1.24 | 1.19 | 1.2 |
mesodermal cell fate commitment | 16 | 1.47 | 1.02 | 1.02 | -1.04 | 1.04 | 1.32 | 1.13 |
endodermal cell fate commitment | 1 | 8.12 | -1.58 | 1.44 | -1.54 | 1.01 | 1.69 | 1.21 |
ectodermal cell fate commitment | 2 | 4.98 | -1.19 | 1.75 | -1.46 | 1.16 | 1.31 | 1.35 |
ectodermal cell fate specification | 2 | 4.98 | -1.19 | 1.75 | -1.46 | 1.16 | 1.31 | 1.35 |
intermediate filament | 2 | 1.28 | 1.06 | -1.0 | 1.32 | 1.15 | -1.17 | -1.1 |
ruffle | 2 | 1.28 | 1.39 | 2.24 | -1.02 | 2.03 | 1.81 | 1.72 |
lipid kinase activity | 2 | 1.57 | 1.08 | 1.68 | -1.01 | 1.59 | 1.77 | 1.96 |
ceramide kinase activity | 1 | 2.79 | -1.02 | 1.66 | -1.11 | 1.24 | 2.25 | 2.21 |
establishment of planar polarity | 70 | 1.2 | 1.06 | 1.23 | 1.01 | 1.28 | 1.24 | 1.46 |
establishment of imaginal disc-derived wing hair orientation | 22 | 1.56 | 1.08 | 1.28 | 1.02 | 1.4 | 1.32 | 1.3 |
morphogenesis of a polarized epithelium | 79 | 1.19 | 1.08 | 1.28 | 1.02 | 1.3 | 1.27 | 1.44 |
oenocyte differentiation | 8 | 1.23 | 1.09 | 1.12 | 1.12 | 1.24 | 1.37 | 1.16 |
optic placode formation | 4 | -1.14 | 1.1 | 1.23 | 1.12 | 1.47 | -1.2 | -1.08 |
optic lobe placode formation | 4 | -1.14 | 1.1 | 1.23 | 1.12 | 1.47 | -1.2 | -1.08 |
compound eye morphogenesis | 198 | 1.16 | 1.1 | 1.25 | 1.06 | 1.25 | 1.2 | 1.26 |
Bolwig's organ morphogenesis | 9 | 1.23 | -1.01 | 1.15 | 1.06 | 1.23 | 1.18 | 1.03 |
optic lobe placode development | 8 | -1.18 | 1.11 | 1.22 | 1.1 | 1.34 | -1.02 | 1.03 |
compound eye photoreceptor cell differentiation | 117 | 1.22 | 1.11 | 1.3 | 1.08 | 1.29 | 1.25 | 1.2 |
compound eye photoreceptor fate commitment | 51 | 1.32 | 1.09 | 1.23 | 1.09 | 1.32 | 1.24 | 1.18 |
compound eye photoreceptor development | 60 | 1.11 | 1.12 | 1.33 | 1.04 | 1.24 | 1.21 | 1.22 |
eye photoreceptor cell differentiation | 120 | 1.21 | 1.12 | 1.32 | 1.08 | 1.29 | 1.26 | 1.21 |
morphogenesis of a branching structure | 48 | 1.11 | 1.11 | 1.43 | 1.03 | 1.35 | 1.27 | 1.3 |
neuron migration | 1 | -1.42 | 1.01 | 1.2 | 1.29 | 2.44 | -1.59 | 1.35 |
cell activation | 10 | 1.19 | 1.04 | 1.07 | 1.06 | -1.05 | 1.15 | 1.06 |
phosphotyrosine binding | 1 | -1.42 | 1.22 | 1.22 | 1.19 | 1.41 | -1.04 | -1.04 |
kidney development | 3 | -1.1 | -1.05 | -1.04 | -1.15 | -1.04 | 1.01 | 1.54 |
epithelial to mesenchymal transition | 1 | 1.47 | 1.13 | -1.02 | 1.1 | -1.07 | -1.03 | 1.1 |
embryonic epithelial tube formation | 6 | 1.03 | -1.09 | 1.01 | -1.18 | -1.08 | 1.45 | 1.48 |
opsonin receptor activity | 1 | 1.18 | 1.16 | 1.11 | 1.22 | 1.12 | 1.2 | 1.16 |
pattern binding | 116 | -1.88 | -1.54 | -1.66 | -1.39 | -1.53 | -1.88 | 1.19 |
response to yeast | 1 | 5.18 | -1.34 | 1.33 | -1.5 | 1.33 | 6.7 | 1.77 |
nucleoside binding | 5 | -2.97 | 1.34 | -1.45 | 1.07 | -1.17 | -2.3 | -1.24 |
endothelial cell development | 3 | 1.7 | 1.01 | 1.41 | -1.21 | 1.32 | 4.52 | 2.14 |
selenium compound metabolic process | 2 | 1.76 | 1.25 | 1.23 | 1.04 | 1.04 | 1.62 | -1.07 |
glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity | 1 | 1.03 | 1.3 | 1.31 | 1.09 | 1.28 | -1.03 | 1.49 |
tissue homeostasis | 20 | 1.33 | -1.02 | 1.13 | -1.12 | 1.22 | 1.46 | 1.54 |
retina homeostasis | 2 | -1.1 | 1.15 | 1.07 | 1.1 | 1.01 | 1.07 | 1.17 |
regulation of protein phosphorylation | 65 | 1.23 | 1.16 | 1.37 | 1.12 | 1.3 | 1.37 | 1.18 |
negative regulation of protein phosphorylation | 2 | -1.04 | 1.11 | 1.79 | -1.0 | 1.29 | 1.24 | 1.01 |
positive regulation of protein phosphorylation | 5 | 1.08 | 1.17 | 1.78 | 1.11 | 1.35 | 1.9 | 1.34 |
regulation of cell-matrix adhesion | 2 | 1.91 | 1.0 | 2.08 | 1.07 | 1.96 | 1.63 | 1.31 |
negative regulation of cell-matrix adhesion | 1 | 2.96 | 1.13 | 1.75 | -1.2 | 1.98 | 1.94 | 1.75 |
startle response | 13 | 1.09 | 1.15 | 1.46 | 1.07 | 1.52 | 1.19 | 1.26 |
G-protein alpha-subunit binding | 2 | -1.16 | 1.18 | -1.02 | 1.16 | 1.01 | -1.6 | -1.07 |
morphogenesis of an epithelium | 238 | 1.18 | 1.05 | 1.28 | 1.02 | 1.3 | 1.33 | 1.27 |
morphogenesis of an epithelial sheet | 1 | 1.57 | 1.36 | 1.53 | 1.09 | 1.59 | 1.28 | 1.35 |
regulation of heart rate | 3 | -2.33 | 1.98 | 1.4 | -1.73 | -1.39 | 2.29 | -1.17 |
regulation of sodium ion transport | 6 | -1.09 | 1.11 | 1.21 | 1.02 | 1.05 | -1.15 | 1.01 |
p53 binding | 1 | 1.78 | 1.16 | 2.67 | 1.12 | 2.53 | 3.19 | 2.15 |
positive regulation of neuroblast proliferation | 2 | -1.35 | 1.28 | 1.19 | 1.29 | 1.21 | -1.02 | 1.09 |
epithelial cell development | 14 | 1.16 | 1.1 | 1.33 | 1.01 | 1.23 | 1.71 | 1.39 |
protein depalmitoylation | 2 | 2.75 | 1.12 | 1.29 | 1.19 | 1.61 | 1.16 | 1.22 |
regulation of receptor internalization | 2 | 2.64 | -1.34 | 1.04 | -1.28 | -1.11 | 2.63 | 1.36 |
positive regulation of receptor internalization | 2 | 2.64 | -1.34 | 1.04 | -1.28 | -1.11 | 2.63 | 1.36 |
polyprenyltransferase activity | 1 | 1.04 | 1.26 | 1.1 | 1.28 | -1.02 | -1.97 | -1.12 |
tRNA wobble base modification | 2 | 1.94 | 1.19 | 1.23 | 1.17 | 1.27 | 1.92 | 1.12 |
tRNA wobble uridine modification | 2 | 1.94 | 1.19 | 1.23 | 1.17 | 1.27 | 1.92 | 1.12 |
podosome | 1 | -1.23 | -1.76 | -1.82 | -1.76 | -2.16 | 17.9 | -1.88 |
store-operated calcium entry | 1 | 2.66 | -1.14 | 1.6 | 1.07 | 1.44 | 4.2 | 2.14 |
aggressive behavior | 44 | 1.19 | 1.05 | 1.23 | -1.02 | 1.15 | 1.61 | 1.24 |
inter-male aggressive behavior | 42 | 1.18 | 1.06 | 1.2 | 1.0 | 1.15 | 1.58 | 1.25 |
G-quadruplex RNA binding | 1 | 1.1 | 1.52 | 1.31 | 1.18 | 1.34 | 1.42 | 1.38 |
larval development | 73 | 1.16 | 1.08 | 1.33 | 1.02 | 1.21 | 1.2 | 1.27 |
instar larval or pupal development | 424 | 1.18 | 1.05 | 1.22 | 1.02 | 1.26 | 1.27 | 1.22 |
instar larval development | 48 | 1.09 | 1.08 | 1.31 | 1.01 | 1.22 | 1.22 | 1.26 |
palmitoyltransferase complex | 1 | -1.92 | 1.11 | 2.34 | 1.27 | 1.64 | -1.44 | -1.26 |
defense response to insect | 1 | 23.01 | -3.14 | -2.9 | -3.17 | -2.48 | 1.73 | 2.58 |
positive regulation of antimicrobial peptide production | 1 | -1.72 | 1.19 | -1.18 | 1.31 | 1.64 | 3.16 | 1.11 |
innate immune response in mucosa | 1 | -1.37 | -1.13 | -1.19 | -1.54 | 1.82 | 7.35 | 2.8 |
response to molecule of bacterial origin | 3 | 2.15 | 1.03 | 1.06 | -1.04 | 1.33 | 1.63 | 1.06 |
adaptive immune response | 2 | -2.37 | 1.1 | 1.16 | -1.04 | 1.34 | -1.89 | 1.24 |
organ or tissue specific immune response | 7 | 1.24 | 1.06 | 1.29 | -1.06 | 1.56 | 1.62 | 1.43 |
immune effector process | 20 | 1.79 | -1.15 | 1.28 | -1.11 | 1.26 | 1.41 | 1.26 |
activation of immune response | 1 | 1.17 | 1.46 | 1.63 | 1.36 | 1.42 | 1.78 | 1.19 |
myeloid leukocyte activation | 1 | 2.18 | -2.11 | 2.19 | 1.49 | 1.48 | 1.37 | 1.38 |
immune system process | 193 | 1.3 | -1.15 | -1.02 | -1.12 | 1.05 | 1.17 | 1.2 |
mucosal immune response | 7 | 1.24 | 1.06 | 1.29 | -1.06 | 1.56 | 1.62 | 1.43 |
immune response-regulating cell surface receptor signaling pathway involved in phagocytosis | 3 | 1.28 | -1.17 | 2.05 | 1.18 | 1.64 | 1.24 | 1.18 |
inflammatory response to antigenic stimulus | 2 | -2.37 | 1.1 | 1.16 | -1.04 | 1.34 | -1.89 | 1.24 |
acute inflammatory response to antigenic stimulus | 2 | -2.37 | 1.1 | 1.16 | -1.04 | 1.34 | -1.89 | 1.24 |
production of molecular mediator of immune response | 2 | -1.54 | 1.11 | 1.81 | 1.12 | 1.7 | 3.17 | 1.43 |
leukocyte mediated immunity | 2 | -2.37 | 1.1 | 1.16 | -1.04 | 1.34 | -1.89 | 1.24 |
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 2 | -2.37 | 1.1 | 1.16 | -1.04 | 1.34 | -1.89 | 1.24 |
immune system development | 52 | 1.16 | 1.07 | 1.33 | 1.05 | 1.3 | 1.2 | 1.34 |
hypersensitivity | 2 | -2.37 | 1.1 | 1.16 | -1.04 | 1.34 | -1.89 | 1.24 |
acute inflammatory response | 3 | -1.45 | 1.14 | 1.29 | 1.15 | 1.43 | -1.36 | 1.17 |
regulation of immune system process | 73 | 1.33 | -1.01 | 1.08 | -1.01 | 1.11 | 1.27 | 1.26 |
negative regulation of immune system process | 16 | 1.45 | 1.01 | 1.09 | -1.01 | 1.17 | 1.27 | 1.37 |
positive regulation of immune system process | 8 | 1.43 | 1.03 | 1.15 | 1.01 | 1.19 | 1.8 | 1.48 |
regulation of immune effector process | 36 | 1.47 | -1.08 | 1.0 | -1.04 | 1.04 | 1.31 | 1.19 |
positive regulation of immune effector process | 1 | -1.72 | 1.19 | -1.18 | 1.31 | 1.64 | 3.16 | 1.11 |
regulation of production of molecular mediator of immune response | 34 | 1.45 | -1.09 | -1.02 | -1.05 | 1.03 | 1.32 | 1.2 |
positive regulation of production of molecular mediator of immune response | 1 | -1.72 | 1.19 | -1.18 | 1.31 | 1.64 | 3.16 | 1.11 |
regulation of antimicrobial humoral response | 39 | 1.26 | -1.07 | 1.01 | -1.04 | 1.05 | 1.16 | 1.17 |
antimicrobial peptide production | 2 | -1.54 | 1.11 | 1.81 | 1.12 | 1.7 | 3.17 | 1.43 |
antifungal peptide production | 1 | -1.72 | 1.19 | -1.18 | 1.31 | 1.64 | 3.16 | 1.11 |
regulation of antimicrobial peptide production | 34 | 1.45 | -1.09 | -1.02 | -1.05 | 1.03 | 1.32 | 1.2 |
regulation of antibacterial peptide production | 19 | 1.47 | -1.12 | 1.02 | -1.12 | 1.06 | 1.26 | 1.29 |
regulation of antifungal peptide production | 7 | 2.0 | -1.32 | -1.17 | 1.03 | 1.03 | 1.92 | 1.18 |
peptide secretion | 1 | 1.36 | -1.09 | 1.47 | 1.03 | 1.67 | -1.23 | 2.47 |
regulation of peptide secretion | 1 | 1.12 | 1.15 | 1.24 | 1.0 | 1.0 | 1.1 | -1.06 |
positive regulation of peptide secretion | 1 | 1.12 | 1.15 | 1.24 | 1.0 | 1.0 | 1.1 | -1.06 |
positive regulation of antifungal peptide production | 1 | -1.72 | 1.19 | -1.18 | 1.31 | 1.64 | 3.16 | 1.11 |
regulation of antimicrobial peptide biosynthetic process | 34 | 1.45 | -1.09 | -1.02 | -1.05 | 1.03 | 1.32 | 1.2 |
negative regulation of antimicrobial peptide biosynthetic process | 2 | 1.03 | 1.14 | 1.57 | 1.07 | 1.57 | -1.03 | -1.32 |
positive regulation of antimicrobial peptide biosynthetic process | 23 | 1.75 | -1.22 | -1.09 | -1.11 | -1.01 | 1.39 | 1.29 |
regulation of antibacterial peptide biosynthetic process | 19 | 1.47 | -1.12 | 1.02 | -1.12 | 1.06 | 1.26 | 1.29 |
negative regulation of antibacterial peptide biosynthetic process | 2 | 1.03 | 1.14 | 1.57 | 1.07 | 1.57 | -1.03 | -1.32 |
regulation of antifungal peptide biosynthetic process | 6 | 2.45 | -1.42 | -1.16 | -1.01 | -1.05 | 1.77 | 1.2 |
regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria | 7 | 1.96 | -1.11 | 1.11 | -1.19 | 1.09 | 1.65 | 1.22 |
negative regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria | 2 | 1.03 | 1.14 | 1.57 | 1.07 | 1.57 | -1.03 | -1.32 |
regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria | 4 | 1.05 | -1.9 | -2.24 | -1.85 | -1.9 | -1.18 | 1.68 |
regulation of response to biotic stimulus | 44 | 1.36 | -1.07 | 1.05 | -1.02 | 1.04 | 1.11 | 1.1 |
negative regulation of response to biotic stimulus | 7 | 1.37 | 1.0 | 1.62 | 1.21 | 1.38 | -1.12 | -1.13 |
positive regulation of response to biotic stimulus | 1 | 8.35 | -1.25 | -1.3 | -1.07 | -1.15 | 1.62 | -1.07 |
regulation of humoral immune response | 39 | 1.26 | -1.07 | 1.01 | -1.04 | 1.05 | 1.16 | 1.17 |
negative regulation of humoral immune response | 4 | 1.35 | 1.1 | 1.46 | 1.15 | 1.8 | 1.12 | 1.2 |
generation of a signal involved in cell-cell signaling | 101 | -1.07 | 1.04 | 1.24 | 1.13 | 1.26 | 1.1 | 1.03 |
regionalization | 378 | 1.18 | 1.05 | 1.18 | 1.02 | 1.22 | 1.26 | 1.24 |
developmental process involved in reproduction | 482 | 1.13 | 1.1 | 1.22 | 1.05 | 1.26 | 1.18 | 1.17 |
heart morphogenesis | 12 | 1.02 | -1.01 | 1.12 | 1.1 | 1.36 | 1.23 | 1.2 |
system process | 634 | 1.08 | 1.03 | 1.09 | -1.0 | 1.08 | 1.15 | 1.06 |
skeletal muscle contraction | 2 | -1.89 | -1.52 | -1.42 | -1.43 | -1.62 | -1.61 | 2.67 |
voluntary skeletal muscle contraction | 1 | -1.18 | -1.0 | 1.06 | -1.02 | -1.12 | 1.04 | 1.04 |
muscle system process | 13 | 1.35 | -1.07 | 1.09 | -1.24 | 1.12 | 1.46 | 1.24 |
circulatory system process | 8 | 1.03 | 1.14 | -1.1 | 1.05 | 1.17 | 1.15 | 1.14 |
renal system process | 6 | -4.46 | 1.18 | -1.92 | -1.14 | -3.52 | -1.44 | -1.93 |
heart process | 8 | 1.03 | 1.14 | -1.1 | 1.05 | 1.17 | 1.15 | 1.14 |
detection of carbon dioxide | 2 | -1.18 | -1.02 | 1.02 | -1.08 | -1.1 | -1.05 | -1.18 |
negative regulation of heart induction by canonical Wnt receptor signaling pathway | 3 | 1.09 | 1.1 | 1.13 | 1.08 | 1.18 | 1.14 | 2.09 |
outflow tract morphogenesis | 3 | -1.03 | 1.08 | 1.55 | 1.17 | 2.15 | 1.03 | 1.48 |
regulation of organ formation | 8 | 1.56 | -1.2 | -1.1 | 1.04 | 1.14 | 1.2 | -1.02 |
endothelium development | 3 | 1.7 | 1.01 | 1.41 | -1.21 | 1.32 | 4.52 | 2.14 |
Wnt receptor signaling pathway involved in heart development | 3 | 1.09 | 1.1 | 1.13 | 1.08 | 1.18 | 1.14 | 2.09 |
amino acid transmembrane transport | 30 | -1.61 | -1.12 | -1.51 | -1.16 | -1.02 | -1.08 | -1.1 |
epithelial cell morphogenesis | 9 | 1.12 | 1.09 | 1.33 | 1.05 | 1.18 | 1.38 | 1.22 |
apical constriction | 4 | -1.26 | 1.28 | 1.59 | 1.06 | 1.39 | 1.15 | 1.23 |
cytoneme morphogenesis | 2 | -1.85 | -1.12 | 1.68 | 1.29 | 1.66 | 1.71 | -2.53 |
neural retina development | 1 | -1.1 | -1.15 | -1.07 | -1.18 | 1.52 | 1.28 | 1.24 |
nucleic acid binding | 1407 | 1.18 | 1.11 | 1.19 | 1.1 | 1.2 | 1.16 | 1.11 |
DNA binding | 669 | 1.15 | 1.09 | 1.17 | 1.08 | 1.17 | 1.12 | 1.11 |
DNA helicase activity | 34 | 1.08 | 1.15 | 1.32 | 1.19 | 1.42 | 1.11 | 1.09 |
AT DNA binding | 5 | 1.49 | -1.14 | -1.13 | 1.14 | 1.47 | 1.04 | 1.12 |
bent DNA binding | 2 | 1.7 | 1.14 | 1.37 | 1.1 | 1.36 | 1.18 | 1.22 |
chromatin binding | 72 | 1.18 | 1.18 | 1.3 | 1.16 | 1.38 | 1.26 | 1.23 |
lamin binding | 1 | 1.4 | 1.14 | 1.18 | 1.58 | 1.38 | 1.2 | 1.19 |
damaged DNA binding | 15 | 1.32 | 1.12 | 1.34 | 1.15 | 1.3 | 1.19 | 1.11 |
DNA clamp loader activity | 3 | 1.23 | 1.05 | 1.23 | 1.24 | 1.24 | 1.1 | -1.01 |
double-stranded DNA binding | 10 | 1.24 | 1.11 | 1.11 | 1.14 | 1.22 | 1.09 | -1.07 |
satellite DNA binding | 5 | 1.25 | 1.13 | 1.51 | 1.21 | 1.5 | 1.17 | 1.18 |
single-stranded DNA binding | 13 | -1.04 | 1.24 | 1.4 | 1.15 | 1.2 | 1.2 | 1.1 |
sequence-specific DNA binding transcription factor activity | 411 | 1.09 | 1.04 | 1.09 | 1.01 | 1.1 | 1.11 | 1.09 |
transcription from RNA polymerase I promoter | 6 | 1.31 | 1.13 | 1.31 | 1.22 | 1.28 | 1.23 | 1.04 |
transcription from RNA polymerase II promoter | 91 | 1.33 | 1.12 | 1.23 | 1.17 | 1.25 | 1.17 | 1.11 |
copper ion transport | 7 | -1.13 | 1.18 | 1.31 | 1.05 | -1.07 | 1.09 | 1.04 |
sequence-specific distal enhancer binding RNA polymerase II transcription factor activity | 50 | 1.18 | -1.11 | -1.01 | -1.13 | -1.1 | 1.13 | 1.1 |
ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity | 20 | 1.3 | 1.06 | 1.02 | -1.03 | 1.08 | 1.23 | 1.26 |
steroid hormone receptor activity | 19 | 1.11 | 1.08 | 1.02 | -1.0 | 1.09 | 1.16 | 1.16 |
retinoic acid receptor activity | 1 | 1.03 | 1.25 | 1.07 | 1.02 | 1.08 | 1.24 | 1.08 |
transcription from RNA polymerase III promoter | 12 | 1.28 | 1.21 | 1.25 | 1.18 | 1.32 | 1.03 | 1.12 |
regulation of transcription elongation, DNA-dependent | 18 | -1.27 | 1.2 | 1.28 | -1.03 | -1.04 | -1.12 | 1.41 |
transcription cofactor activity | 90 | 1.26 | 1.11 | 1.26 | 1.16 | 1.34 | 1.25 | 1.15 |
transcription coactivator activity | 41 | 1.32 | 1.06 | 1.24 | 1.13 | 1.34 | 1.33 | 1.18 |
transcription corepressor activity | 19 | 1.19 | 1.16 | 1.26 | 1.18 | 1.37 | 1.12 | 1.16 |
transcription termination, DNA-dependent | 2 | -1.11 | 1.05 | 1.39 | 1.1 | 1.37 | 1.26 | -1.23 |
termination of RNA polymerase II transcription | 1 | -1.51 | -1.02 | 1.38 | 1.04 | 1.42 | 1.11 | -1.1 |
cytoplasmic sequestering of transcription factor | 4 | 2.74 | 1.08 | 1.33 | 1.02 | 1.2 | 2.19 | 1.75 |
RNA binding | 381 | 1.26 | 1.16 | 1.26 | 1.13 | 1.22 | 1.27 | 1.13 |
RNA helicase activity | 45 | 1.22 | 1.23 | 1.32 | 1.18 | 1.31 | 1.38 | 1.21 |
double-stranded RNA binding | 16 | 1.33 | -1.04 | 1.19 | -1.13 | 1.16 | 1.42 | 1.51 |
double-stranded RNA adenosine deaminase activity | 1 | 1.13 | 1.14 | 1.55 | 1.01 | 1.4 | 2.0 | 1.26 |
single-stranded RNA binding | 20 | 1.32 | 1.14 | 1.42 | 1.11 | 1.32 | 1.44 | 1.23 |
mRNA binding | 170 | 1.24 | 1.17 | 1.28 | 1.15 | 1.25 | 1.26 | 1.16 |
mRNA 3'-UTR binding | 17 | 1.34 | 1.14 | 1.46 | 1.02 | 1.31 | 1.89 | 1.29 |
ribonucleoprotein complex | 427 | 1.18 | 1.1 | 1.2 | 1.16 | 1.24 | 1.21 | -1.02 |
small nuclear ribonucleoprotein complex | 54 | 1.14 | 1.14 | 1.25 | 1.27 | 1.31 | 1.06 | -1.02 |
structural constituent of ribosome | 167 | 1.21 | 1.04 | 1.14 | 1.12 | 1.17 | 1.28 | -1.18 |
translation initiation factor activity | 53 | 1.33 | 1.18 | 1.26 | 1.09 | 1.18 | 1.35 | 1.16 |
translation elongation factor activity | 16 | 1.48 | 1.11 | 1.26 | 1.06 | 1.23 | 1.46 | 1.05 |
translation release factor activity | 7 | 1.27 | 1.16 | 1.25 | 1.13 | 1.18 | 1.49 | 1.09 |
regulation of cell cycle | 240 | 1.19 | 1.13 | 1.28 | 1.13 | 1.34 | 1.28 | 1.16 |
protein folding | 118 | 1.15 | 1.04 | 1.09 | 1.13 | 1.17 | 1.02 | 1.01 |
peptidyl-prolyl cis-trans isomerase activity | 26 | 1.38 | 1.03 | 1.1 | 1.15 | 1.25 | 1.1 | 1.02 |
protein disulfide isomerase activity | 10 | 1.1 | -1.01 | 1.22 | 1.11 | 1.12 | 1.08 | 1.12 |
chromatin assembly or disassembly | 34 | 1.01 | 1.07 | 1.29 | 1.13 | 1.25 | -1.04 | 1.07 |
nucleosome assembly | 27 | 1.02 | 1.05 | 1.3 | 1.15 | 1.22 | -1.07 | 1.03 |
nucleosome organization | 36 | 1.09 | 1.07 | 1.28 | 1.16 | 1.21 | 1.01 | 1.03 |
histone binding | 10 | 1.48 | 1.07 | 1.28 | 1.23 | 1.28 | 1.39 | 1.04 |
histone exchange | 7 | 1.15 | 1.19 | 1.23 | 1.17 | 1.15 | 1.2 | 1.05 |
ATPase activity, coupled | 283 | -1.01 | 1.06 | 1.16 | 1.03 | 1.13 | 1.15 | 1.04 |
chaperone binding | 16 | -1.03 | -1.17 | 1.06 | 1.16 | 1.34 | 1.16 | -1.27 |
response to unfolded protein | 2 | 1.04 | 1.38 | 1.16 | -1.1 | 1.05 | 1.03 | 1.56 |
protein refolding | 7 | 1.25 | 1.05 | 1.14 | -1.0 | 1.11 | -1.26 | 1.35 |
motor activity | 76 | -1.02 | 1.07 | 1.2 | 1.02 | 1.14 | 1.1 | 1.03 |
microtubule motor activity | 51 | 1.03 | 1.09 | 1.15 | 1.06 | 1.12 | 1.1 | 1.04 |
axoneme | 14 | -1.03 | 1.04 | 1.03 | 1.02 | -1.05 | -1.01 | -1.1 |
muscle contraction | 12 | 1.16 | -1.04 | 1.06 | -1.18 | 1.13 | 1.33 | 1.25 |
contractile fiber | 33 | 2.45 | -1.47 | -1.08 | -1.25 | 1.2 | 1.97 | -1.14 |
actin binding | 114 | -1.07 | 1.06 | 1.38 | -1.0 | 1.31 | 1.09 | 1.15 |
protein binding, bridging | 17 | -1.01 | 1.02 | 1.14 | 1.03 | 1.09 | 1.16 | 1.1 |
actin filament binding | 8 | -1.01 | -1.14 | 1.31 | -1.17 | 1.11 | 1.2 | 1.33 |
actin filament bundle assembly | 17 | 1.57 | -1.02 | 1.24 | -1.1 | 1.24 | 1.29 | 1.51 |
barbed-end actin filament capping | 2 | -1.38 | -1.03 | 2.18 | 1.01 | 1.59 | -1.39 | -1.04 |
actin monomer binding | 1 | -3.23 | -1.14 | 1.86 | -1.09 | 2.26 | -4.44 | -1.1 |
actin filament depolymerization | 4 | -1.06 | 1.03 | 1.27 | 1.14 | 1.25 | -1.37 | -1.31 |
actin cytoskeleton organization | 160 | 1.17 | 1.02 | 1.34 | -1.03 | 1.29 | 1.3 | 1.17 |
membrane | 2078 | 1.02 | -1.01 | 1.0 | -1.02 | 1.04 | 1.09 | 1.03 |
regulation of actin filament length | 20 | -1.48 | 1.08 | 1.45 | 1.05 | 1.38 | -1.21 | 1.18 |
defense response | 178 | 1.35 | -1.27 | -1.19 | -1.18 | -1.1 | 1.18 | 1.09 |
acute-phase response | 1 | 1.84 | 1.22 | 1.59 | 1.61 | 1.65 | 1.41 | 1.04 |
lysozyme activity | 14 | 1.98 | -1.64 | -2.07 | -1.66 | -1.61 | -1.16 | 1.06 |
defense response to bacterium | 84 | 1.33 | -1.21 | -1.16 | -1.18 | -1.05 | 1.15 | 1.15 |
male-specific defense response to bacterium | 1 | -1.1 | -1.03 | -1.03 | -1.0 | -1.23 | -1.2 | -1.1 |
defense response to fungus | 28 | 1.68 | -1.27 | -1.31 | -1.29 | -1.25 | 1.08 | 1.24 |
response to virus | 12 | 2.35 | -1.64 | -1.09 | -1.61 | 1.07 | 1.84 | 1.26 |
serine-type endopeptidase activity | 263 | -2.24 | -1.42 | -1.67 | -1.14 | -1.46 | -2.32 | -1.65 |
blood coagulation | 1 | 1.05 | 1.37 | 1.17 | 1.34 | 1.05 | 1.15 | 1.1 |
protein-glutamine gamma-glutamyltransferase activity | 2 | 5.84 | -1.94 | -1.03 | -1.59 | -1.03 | 2.32 | 1.28 |
antigen binding | 1 | -1.71 | -1.18 | -1.3 | -1.15 | -1.23 | -1.3 | 1.07 |
catalytic activity | 3804 | -1.08 | -1.02 | -1.07 | 1.01 | 1.04 | -1.07 | -1.05 |
alpha,alpha-trehalose-phosphate synthase (UDP-forming) activity | 1 | 1.32 | -4.96 | -6.02 | -4.98 | -1.62 | 7.64 | -3.94 |
alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity | 1 | 3.18 | 1.02 | 1.47 | 1.11 | 1.44 | 4.09 | 2.36 |
beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity | 1 | 3.39 | -1.12 | 1.06 | -1.11 | 1.06 | 1.27 | -1.12 |
beta-alanyl-dopamine hydrolase activity | 1 | -1.31 | -1.76 | 1.72 | 1.22 | 1.97 | 3.11 | 1.28 |
beta-alanyl-dopamine synthase activity | 1 | 1.36 | 1.09 | 1.02 | -1.03 | -1.16 | 1.04 | 1.01 |
beta-carotene 15,15'-monooxygenase activity | 1 | 1.12 | -1.01 | 1.14 | 1.06 | 1.09 | 1.14 | -1.06 |
beta-galactoside alpha-2,6-sialyltransferase activity | 1 | 1.19 | 1.12 | 1.07 | 1.08 | 1.03 | 1.22 | -1.05 |
beta-ureidopropionase activity | 1 | 17.28 | -3.07 | -1.83 | -2.92 | -2.4 | 3.32 | 1.6 |
gamma-glutamylcyclotransferase activity | 2 | 1.29 | 1.27 | 1.3 | -1.14 | -1.14 | 1.15 | -1.11 |
gamma-glutamyltransferase activity | 4 | 1.24 | -1.34 | -1.15 | 1.08 | 1.94 | 1.31 | -1.06 |
1-acylglycerol-3-phosphate O-acyltransferase activity | 6 | -1.56 | -1.19 | -1.0 | 1.18 | 2.24 | -2.62 | -1.99 |
1-pyrroline-5-carboxylate dehydrogenase activity | 3 | 1.56 | -1.48 | -1.15 | -1.62 | -1.43 | 2.14 | 1.15 |
1,3-beta-D-glucan synthase activity | 1 | 12.72 | -1.88 | -1.16 | -3.3 | -1.54 | 3.13 | 2.87 |
1,4-alpha-glucan branching enzyme activity | 1 | 3.55 | -1.35 | -1.97 | 1.08 | 1.09 | 1.58 | 1.19 |
1-alkyl-2-acetylglycerophosphocholine esterase activity | 1 | 3.85 | 1.07 | 1.8 | 1.09 | 1.57 | 2.16 | 1.8 |
2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity | 5 | -4.34 | 1.01 | 1.27 | 1.24 | 1.5 | -3.41 | -1.26 |
3-beta-hydroxy-delta5-steroid dehydrogenase activity | 1 | 7.52 | -1.63 | -1.52 | -1.44 | -1.48 | 2.76 | 1.78 |
3-hydroxyacyl-CoA dehydrogenase activity | 4 | 1.05 | 1.0 | -1.41 | 1.24 | -1.28 | 1.08 | 1.21 |
3-hydroxyisobutyryl-CoA hydrolase activity | 1 | 1.35 | 1.24 | 1.18 | -1.16 | -1.11 | 6.95 | -1.22 |
3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity | 2 | 1.67 | 1.29 | 1.69 | -1.02 | 1.34 | 1.99 | 1.11 |
3-oxo-5-alpha-steroid 4-dehydrogenase activity | 1 | -1.31 | 1.28 | -1.32 | 1.3 | 1.08 | -2.32 | -1.18 |
4-aminobutyrate transaminase activity | 1 | -1.88 | 3.07 | -1.92 | -1.52 | -1.3 | -2.05 | 1.06 |
4-hydroxyphenylpyruvate dioxygenase activity | 1 | 1.86 | -1.07 | 1.21 | 1.03 | 1.14 | 1.09 | -1.06 |
4-nitrophenylphosphatase activity | 9 | -1.32 | 1.18 | -1.3 | 1.06 | 1.01 | -1.31 | 1.07 |
5-aminolevulinate synthase activity | 1 | 1.58 | 1.36 | -1.31 | -1.09 | -1.26 | 1.25 | 1.23 |
6-phosphofructokinase activity | 1 | 2.63 | -1.22 | -1.22 | 1.02 | -1.12 | 5.11 | 1.3 |
6-phosphofructo-2-kinase activity | 1 | 1.09 | -1.34 | 2.59 | -1.04 | 1.14 | 3.38 | -1.06 |
6-pyruvoyltetrahydropterin synthase activity | 1 | 2.12 | 1.31 | 1.32 | 1.23 | 1.73 | 1.01 | 2.0 |
AMP deaminase activity | 1 | 1.21 | 1.11 | 1.3 | -1.14 | 1.24 | 3.4 | 1.06 |
ATP citrate synthase activity | 4 | -1.02 | -1.02 | -1.04 | -1.09 | -1.21 | 1.05 | -1.32 |
protein C-terminal carboxyl O-methyltransferase activity | 1 | -2.13 | 1.18 | 1.09 | 1.41 | 1.8 | -1.71 | -1.76 |
CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity | 1 | 2.1 | -1.04 | 1.71 | -1.1 | 1.9 | -1.29 | 1.13 |
CDP-diacylglycerol-serine O-phosphatidyltransferase activity | 1 | 1.61 | 1.37 | 2.22 | 1.0 | 1.13 | 1.67 | 1.83 |
D-amino-acid oxidase activity | 2 | -2.82 | -1.69 | -2.22 | 1.7 | 1.95 | -1.63 | -1.83 |
DNA (cytosine-5-)-methyltransferase activity | 2 | 1.2 | 1.07 | 1.01 | 1.32 | 1.13 | -1.12 | -1.02 |
DNA-directed DNA polymerase activity | 18 | 1.05 | 1.09 | 1.17 | 1.07 | 1.16 | 1.1 | -1.1 |
DNA primase activity | 2 | 1.15 | 1.13 | 1.17 | 1.19 | 1.37 | 1.14 | -1.16 |
DNA-directed RNA polymerase activity | 28 | 1.31 | 1.12 | 1.19 | 1.24 | 1.24 | 1.06 | 1.0 |
deoxyribodipyrimidine photo-lyase activity | 1 | -1.34 | -1.01 | -1.03 | 1.23 | 1.09 | -1.47 | -1.1 |
DNA-(apurinic or apyrimidinic site) lyase activity | 5 | 1.72 | -1.0 | 1.07 | 1.11 | 1.19 | 1.32 | 1.0 |
methylated-DNA-[protein]-cysteine S-methyltransferase activity | 1 | 1.12 | -1.01 | 1.19 | 1.74 | 1.2 | 1.06 | -1.09 |
DNA ligase activity | 3 | 1.18 | 1.28 | 1.26 | 1.14 | 1.32 | 1.13 | 1.13 |
DNA ligase (ATP) activity | 2 | 1.29 | 1.46 | 1.49 | 1.24 | 1.5 | 1.27 | 1.28 |
DNA photolyase activity | 3 | 1.02 | -1.07 | -1.02 | 1.07 | 1.04 | 1.25 | -1.04 |
DNA (6-4) photolyase activity | 1 | 1.03 | -1.11 | 1.01 | -1.14 | 1.01 | 1.07 | -1.17 |
DNA topoisomerase activity | 7 | 1.03 | 1.16 | 1.23 | 1.17 | 1.3 | 1.13 | 1.25 |
DNA topoisomerase type I activity | 3 | -1.14 | 1.27 | 1.28 | 1.28 | 1.24 | 1.04 | 1.14 |
DNA topoisomerase (ATP-hydrolyzing) activity | 3 | -1.26 | 1.43 | 1.56 | 1.29 | 1.52 | 1.12 | 1.27 |
FMN adenylyltransferase activity | 2 | 1.48 | 1.18 | 1.47 | 1.03 | -1.01 | 1.23 | 1.07 |
GMP synthase activity | 1 | 1.14 | 1.09 | 1.34 | -1.05 | 1.24 | 1.35 | 2.12 |
GMP synthase (glutamine-hydrolyzing) activity | 1 | 1.14 | 1.09 | 1.34 | -1.05 | 1.24 | 1.35 | 2.12 |
GPI-anchor transamidase activity | 1 | 1.21 | 1.1 | 1.8 | 1.25 | 1.66 | -1.16 | 1.35 |
synaptic vesicle uncoating | 2 | -1.44 | 1.22 | 1.71 | 1.06 | 1.91 | 1.53 | 1.42 |
vesicle-mediated transport | 402 | 1.05 | 1.08 | 1.23 | 1.09 | 1.24 | 1.19 | 1.14 |
protein import into nucleus | 36 | 1.11 | 1.22 | 1.35 | 1.2 | 1.37 | 1.25 | 1.17 |
cytoskeleton organization | 516 | 1.14 | 1.08 | 1.28 | 1.06 | 1.28 | 1.2 | 1.11 |
secretion | 145 | -1.04 | 1.05 | 1.22 | 1.11 | 1.24 | 1.07 | 1.07 |
GTP cyclohydrolase activity | 1 | 33.5 | -5.63 | -5.79 | -6.03 | -4.58 | -1.32 | 6.94 |
GTP cyclohydrolase I activity | 1 | 33.5 | -5.63 | -5.79 | -6.03 | -4.58 | -1.32 | 6.94 |
hydrogen ion transporting ATP synthase activity, rotational mechanism | 16 | 1.35 | -1.04 | 1.11 | -1.09 | -1.01 | 1.54 | -1.13 |
IMP cyclohydrolase activity | 1 | -1.39 | 1.0 | -1.49 | -1.01 | -1.06 | 1.63 | -1.09 |
IMP dehydrogenase activity | 1 | 1.16 | 1.34 | 1.12 | 1.03 | 1.08 | -1.1 | 1.99 |
L-iditol 2-dehydrogenase activity | 3 | 1.17 | -1.39 | -1.37 | 1.12 | 1.23 | 1.74 | -1.02 |
L-iduronidase activity | 1 | -1.71 | 1.0 | 1.11 | -1.04 | 1.62 | -1.12 | -1.27 |
N-acetylgalactosamine-4-sulfatase activity | 4 | 1.55 | -1.16 | -1.4 | 1.09 | 1.42 | 2.61 | -1.17 |
N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity | 3 | -1.38 | 1.01 | 1.13 | 1.06 | 1.15 | -1.4 | 1.08 |
NAD+ ADP-ribosyltransferase activity | 1 | -2.18 | 1.38 | 1.41 | 1.1 | 1.13 | -1.47 | 1.05 |
NAD+ kinase activity | 3 | 1.2 | 1.17 | -1.08 | 1.1 | 1.06 | -1.04 | 1.02 |
NAD+ synthase (glutamine-hydrolyzing) activity | 1 | 2.07 | 1.6 | 1.04 | 1.19 | 1.4 | 2.13 | 1.77 |
NADH dehydrogenase activity | 36 | 1.13 | 1.03 | 1.27 | 1.06 | 1.1 | 1.72 | -1.29 |
NAD(P)+-protein-arginine ADP-ribosyltransferase activity | 2 | 1.3 | 1.3 | 1.14 | 1.02 | 1.15 | -1.14 | 1.12 |
NADPH-hemoprotein reductase activity | 1 | 1.63 | 1.35 | 1.12 | -1.0 | 1.2 | -1.04 | 1.34 |
NADPH dehydrogenase activity | 1 | -1.51 | 1.45 | 1.08 | 1.06 | -1.12 | -1.58 | -1.42 |
RNA-3'-phosphate cyclase activity | 2 | 1.22 | 1.13 | -1.15 | 1.27 | 1.07 | -1.19 | -1.17 |
RNA-directed DNA polymerase activity | 1 | 1.54 | 1.82 | 1.92 | -1.04 | 1.87 | 1.15 | 2.39 |
UDP-N-acetylglucosamine diphosphorylase activity | 1 | -1.57 | -1.13 | 1.65 | -1.09 | 1.26 | -1.83 | 1.72 |
UDP-glucose 4-epimerase activity | 3 | -1.33 | 1.08 | -1.17 | -1.19 | -1.1 | -1.47 | 1.1 |
UDP-glucose:glycoprotein glucosyltransferase activity | 1 | 1.21 | 1.16 | 1.35 | -1.04 | 1.59 | 1.69 | 2.54 |
UTP:glucose-1-phosphate uridylyltransferase activity | 1 | 1.07 | -1.0 | -1.14 | -1.11 | -1.05 | -1.01 | 1.08 |
acetyl-CoA C-acetyltransferase activity | 2 | 1.25 | 1.16 | -1.11 | 1.2 | -1.13 | 1.26 | -1.35 |
acetate-CoA ligase activity | 2 | 1.63 | 1.11 | -1.36 | -1.04 | -1.71 | 1.16 | 1.18 |
acetyl-CoA C-acyltransferase activity | 4 | 1.58 | 1.11 | -1.25 | 1.12 | 1.08 | 1.06 | -1.32 |
acetyl-CoA carboxylase activity | 1 | 7.73 | 1.2 | -1.41 | -2.71 | 1.2 | 3.14 | 4.69 |
acetylcholinesterase activity | 1 | 2.27 | 1.23 | -5.17 | -1.59 | -2.2 | -9.9 | 9.42 |
acid phosphatase activity | 12 | 1.44 | 1.13 | -1.05 | -1.03 | -1.02 | 1.81 | 1.28 |
aconitate hydratase activity | 4 | 1.11 | 1.25 | 1.22 | -1.14 | -1.03 | 1.75 | 1.32 |
acyl-CoA dehydrogenase activity | 15 | -1.17 | 1.11 | -1.37 | 1.1 | 1.1 | -1.79 | -1.3 |
acyl-CoA oxidase activity | 6 | -2.19 | 1.03 | -1.7 | 1.08 | 1.14 | -3.66 | -1.47 |
acylphosphatase activity | 6 | 1.57 | 1.0 | -1.02 | 1.01 | -1.1 | 1.04 | -1.12 |
adenine phosphoribosyltransferase activity | 1 | 1.17 | 1.37 | 1.23 | 1.24 | 1.3 | 1.33 | -1.5 |
adenosine deaminase activity | 8 | -1.69 | 1.1 | 1.06 | -1.03 | -1.09 | 1.15 | -1.16 |
adenosine kinase activity | 4 | 1.16 | 1.08 | -1.11 | 1.18 | 1.12 | 1.14 | -1.1 |
ATP-dependent DNA helicase activity | 19 | 1.12 | 1.17 | 1.33 | 1.14 | 1.3 | 1.15 | 1.17 |
ATP-dependent RNA helicase activity | 38 | 1.22 | 1.21 | 1.3 | 1.2 | 1.31 | 1.37 | 1.16 |
cation-transporting ATPase activity | 26 | 1.1 | 1.0 | 1.24 | -1.08 | 1.02 | 1.51 | -1.05 |
metal ion transmembrane transporter activity | 144 | -1.31 | -1.08 | -1.41 | -1.18 | -1.18 | 1.02 | -1.13 |
copper-exporting ATPase activity | 1 | -2.22 | 1.33 | 3.02 | 1.07 | -1.16 | -1.12 | 1.08 |
ATPase activity, coupled to transmembrane movement of substances | 120 | -1.08 | -1.04 | 1.03 | -1.07 | 1.02 | 1.16 | -1.05 |
ATP-binding cassette (ABC) transporter complex | 41 | 1.23 | -1.2 | -1.24 | -1.08 | 1.0 | 1.04 | -1.04 |
phospholipid-translocating ATPase activity | 6 | -2.65 | 1.11 | -1.12 | 1.22 | 1.24 | -1.33 | -1.09 |
adenosylhomocysteinase activity | 3 | -2.93 | -1.82 | -1.21 | -1.07 | 1.22 | 1.86 | -1.16 |
adenosylmethionine decarboxylase activity | 1 | 1.82 | 1.07 | 1.08 | 1.22 | 1.03 | 1.75 | -1.05 |
adenylate cyclase activity | 12 | 1.43 | 1.1 | 1.07 | -1.04 | 1.13 | 1.5 | 1.22 |
adenylate kinase activity | 6 | 1.61 | -1.18 | 1.01 | 1.04 | 1.05 | 1.04 | -1.33 |
N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity | 1 | 1.1 | 1.08 | 1.31 | 1.11 | 1.27 | 1.3 | 1.19 |
adenylosuccinate synthase activity | 1 | 2.08 | 1.19 | 1.56 | -1.1 | -1.15 | 1.56 | -1.05 |
adenylylsulfate kinase activity | 1 | -2.63 | 1.06 | 1.41 | 1.07 | 1.11 | -1.64 | -1.02 |
L-alanine:2-oxoglutarate aminotransferase activity | 1 | -2.33 | 1.13 | 1.14 | 1.09 | 1.76 | 1.77 | -1.09 |
alcohol dehydrogenase (NAD) activity | 5 | 1.66 | -1.09 | -1.8 | -1.39 | -1.21 | 1.37 | 1.27 |
aldehyde dehydrogenase (NAD) activity | 3 | -1.65 | 1.15 | -1.65 | 1.05 | -1.41 | -1.9 | -1.31 |
aldehyde dehydrogenase [NAD(P)+] activity | 1 | 1.67 | -1.24 | -1.26 | 1.36 | 2.03 | -1.43 | 1.25 |
alditol:NADP+ 1-oxidoreductase activity | 6 | -1.18 | 1.24 | -1.3 | -1.16 | -1.25 | -1.07 | 1.15 |
aldo-keto reductase (NADP) activity | 7 | 1.25 | 1.15 | -1.37 | -1.18 | -1.21 | 1.14 | 1.22 |
aldose 1-epimerase activity | 3 | -1.46 | 1.17 | -1.47 | -1.07 | 1.13 | -1.58 | -1.03 |
alkaline phosphatase activity | 13 | -5.32 | -1.81 | -4.2 | -1.19 | -1.19 | -4.42 | -4.05 |
allantoinase activity | 1 | 2.85 | -1.01 | 1.16 | 1.03 | -1.08 | 1.74 | -1.1 |
amidase activity | 1 | 1.54 | -1.32 | 2.9 | 1.39 | -1.83 | -6.19 | -2.79 |
amidophosphoribosyltransferase activity | 2 | 1.11 | 1.02 | -1.15 | -1.13 | -1.43 | 1.89 | -1.09 |
aminoacyl-tRNA hydrolase activity | 3 | 1.72 | -1.02 | 1.14 | 1.1 | 1.0 | 1.49 | -1.08 |
aminoacylase activity | 6 | -1.72 | -1.86 | -1.07 | -1.63 | 1.29 | -1.6 | -1.71 |
aminomethyltransferase activity | 4 | 1.27 | 1.14 | 1.17 | 1.01 | -1.01 | 1.6 | 1.08 |
nucleoside-diphosphatase activity | 3 | -2.29 | 1.44 | -2.09 | 1.33 | -1.38 | -3.32 | 1.1 |
nucleoside-triphosphatase activity | 535 | 1.04 | 1.07 | 1.18 | 1.06 | 1.16 | 1.12 | 1.03 |
arginase activity | 2 | 1.73 | -1.09 | 1.02 | -1.05 | -1.18 | 2.27 | 1.17 |
arginine kinase activity | 3 | 1.01 | 1.07 | 1.29 | 1.05 | -1.11 | 1.23 | -1.22 |
argininosuccinate synthase activity | 1 | -31.89 | 1.77 | -20.72 | 1.41 | 1.0 | -12.66 | -3.5 |
argininosuccinate lyase activity | 1 | -15.39 | 1.51 | -7.96 | 1.39 | 1.15 | -4.77 | -1.11 |
arginyltransferase activity | 1 | 1.03 | 1.39 | 1.46 | 1.24 | 1.37 | 1.69 | 1.36 |
aromatic-L-amino-acid decarboxylase activity | 4 | 2.04 | -1.66 | -1.74 | -1.59 | -1.59 | 1.51 | 1.84 |
aralkylamine N-acetyltransferase activity | 1 | -8.98 | 1.77 | -2.05 | -1.02 | -2.08 | -14.22 | 1.22 |
arylamine N-acetyltransferase activity | 1 | -8.98 | 1.77 | -2.05 | -1.02 | -2.08 | -14.22 | 1.22 |
aryl sulfotransferase activity | 1 | 1.25 | -1.11 | -1.17 | -1.08 | -1.01 | 1.11 | 1.01 |
aryldialkylphosphatase activity | 1 | 1.9 | -1.44 | -1.39 | -2.02 | 1.17 | 21.38 | -1.25 |
asparagine synthase (glutamine-hydrolyzing) activity | 2 | -1.07 | 1.2 | 1.14 | 1.26 | 1.17 | 1.27 | -1.14 |
asparaginase activity | 4 | 1.31 | -1.05 | -1.24 | -1.15 | 1.04 | 1.97 | 1.03 |
aspartate 1-decarboxylase activity | 1 | 1.44 | -1.11 | -1.15 | 1.16 | -1.17 | -1.1 | -1.2 |
L-aspartate:2-oxoglutarate aminotransferase activity | 2 | 1.83 | 1.18 | -1.32 | -1.0 | 1.19 | 1.57 | 1.14 |
aspartate carbamoyltransferase activity | 1 | -1.12 | 1.14 | 1.63 | 1.21 | 1.33 | 1.0 | 1.05 |
biliverdin reductase activity | 1 | -1.51 | 1.45 | 1.08 | 1.06 | -1.12 | -1.58 | -1.42 |
biotin carboxylase activity | 3 | 2.88 | 1.25 | -1.21 | -1.16 | -1.0 | 2.26 | 1.91 |
biotin-[acetyl-CoA-carboxylase] ligase activity | 1 | 1.43 | 1.46 | 1.44 | 1.24 | 1.28 | 1.18 | 1.38 |
biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity | 1 | 1.43 | 1.46 | 1.44 | 1.24 | 1.28 | 1.18 | 1.38 |
bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity | 1 | -1.85 | 1.12 | 1.37 | 1.12 | 1.23 | -1.02 | 1.02 |
branched-chain-amino-acid transaminase activity | 1 | 5.21 | 1.63 | 1.44 | -1.45 | -2.46 | 1.42 | 2.6 |
carbamoyl-phosphate synthase (ammonia) activity | 1 | -1.12 | 1.14 | 1.63 | 1.21 | 1.33 | 1.0 | 1.05 |
carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 1 | -1.12 | 1.14 | 1.63 | 1.21 | 1.33 | 1.0 | 1.05 |
carbonate dehydratase activity | 17 | -1.34 | -1.07 | 1.2 | -1.25 | 1.01 | 1.12 | 1.01 |
carbonyl reductase (NADPH) activity | 3 | 1.57 | 1.0 | -1.52 | -1.25 | -1.09 | 1.43 | 1.09 |
carboxylesterase activity | 33 | -1.1 | 1.01 | -1.29 | -1.03 | -1.13 | -1.36 | -1.13 |
carnitine O-acetyltransferase activity | 3 | -1.35 | 1.07 | -1.21 | 1.11 | 1.17 | -1.19 | -1.2 |
carnitine O-palmitoyltransferase activity | 1 | 1.55 | 1.41 | -1.09 | 1.13 | 1.34 | -1.06 | 1.05 |
catalase activity | 3 | 1.88 | -1.66 | -2.02 | -1.59 | -1.55 | 2.15 | -1.21 |
catechol oxidase activity | 1 | 1.73 | 1.33 | 1.02 | 1.13 | -1.06 | -1.05 | 1.06 |
chitin deacetylase activity | 2 | 2.14 | -1.13 | 1.05 | -1.06 | -1.29 | -1.18 | -1.25 |
chitin synthase activity | 2 | -4.74 | 1.25 | 1.37 | -1.3 | 1.38 | 1.09 | 1.15 |
choline O-acetyltransferase activity | 1 | 1.49 | -1.03 | -1.23 | 1.03 | 1.04 | -1.13 | 1.06 |
choline kinase activity | 2 | 1.11 | 1.13 | 1.36 | 1.19 | 1.43 | 2.57 | 1.13 |
cholinesterase activity | 2 | -1.12 | 1.28 | -2.63 | -1.13 | -1.28 | -3.75 | 2.43 |
choline-phosphate cytidylyltransferase activity | 2 | 1.06 | -1.23 | 1.07 | 1.02 | 1.15 | -1.4 | 1.55 |
citrate (Si)-synthase activity | 1 | -1.05 | 1.1 | -1.11 | 1.07 | -1.23 | -1.06 | -1.08 |
coproporphyrinogen oxidase activity | 1 | -1.38 | 1.31 | 1.39 | 1.26 | 1.22 | -1.88 | -1.39 |
cyclic-nucleotide phosphodiesterase activity | 8 | 1.68 | 1.07 | 1.28 | 1.01 | 1.26 | 2.25 | 1.48 |
3',5'-cyclic-nucleotide phosphodiesterase activity | 8 | 1.68 | 1.07 | 1.28 | 1.01 | 1.26 | 2.25 | 1.48 |
3',5'-cyclic-AMP phosphodiesterase activity | 4 | 1.06 | 1.26 | 1.31 | 1.05 | 1.3 | 1.79 | 1.4 |
calmodulin-dependent cyclic-nucleotide phosphodiesterase activity | 1 | -1.09 | -1.0 | 1.07 | 1.3 | -1.04 | -1.15 | -1.07 |
cystathionine beta-synthase activity | 1 | 1.25 | 1.1 | 1.48 | -1.98 | -7.11 | -1.17 | 2.59 |
cystathionine gamma-lyase activity | 2 | 1.42 | 1.32 | 1.04 | 1.04 | 1.07 | -1.09 | 1.37 |
cytidine deaminase activity | 3 | -2.8 | 1.04 | -1.39 | 1.2 | 1.32 | -1.87 | -1.06 |
cytidylate kinase activity | 1 | -1.35 | 1.03 | 1.12 | 1.16 | 1.1 | -1.2 | -1.23 |
cytochrome-b5 reductase activity | 1 | -1.1 | 1.03 | -1.07 | 1.37 | 1.05 | -1.32 | 1.01 |
cytochrome-c oxidase activity | 18 | -1.12 | -1.08 | 1.07 | -1.07 | 1.03 | 1.19 | -1.31 |
cytosine deaminase activity | 1 | 1.58 | 1.21 | -1.04 | 1.33 | -1.0 | -1.93 | 1.34 |
dCMP deaminase activity | 1 | 2.54 | -1.17 | -1.05 | 1.35 | 1.96 | 1.77 | -1.1 |
glycogen debranching enzyme activity | 1 | 1.91 | -1.57 | -1.98 | 1.36 | -1.16 | 2.47 | 1.07 |
4-alpha-glucanotransferase activity | 1 | 1.91 | -1.57 | -1.98 | 1.36 | -1.16 | 2.47 | 1.07 |
amylo-alpha-1,6-glucosidase activity | 1 | 1.91 | -1.57 | -1.98 | 1.36 | -1.16 | 2.47 | 1.07 |
deoxyribose-phosphate aldolase activity | 1 | -1.52 | 1.52 | -1.38 | 1.37 | -1.06 | -2.8 | 1.21 |
dephospho-CoA kinase activity | 2 | 1.04 | 1.25 | -1.2 | 1.45 | 1.19 | -1.52 | -1.32 |
diacylglycerol cholinephosphotransferase activity | 1 | -3.65 | 1.65 | 3.17 | 1.08 | 1.15 | -2.09 | 2.51 |
diacylglycerol kinase activity | 8 | 1.65 | 1.05 | -1.03 | -1.02 | -1.04 | 1.17 | 1.24 |
diacylglycerol O-acyltransferase activity | 1 | -1.05 | 1.33 | 3.49 | 1.16 | 1.98 | 2.09 | 1.25 |
dihydrofolate reductase activity | 1 | 2.25 | -1.1 | -1.03 | 1.28 | 1.09 | 2.14 | -1.24 |
dihydrolipoamide branched chain acyltransferase activity | 1 | 1.74 | 1.44 | 1.67 | 1.01 | 1.35 | 1.38 | 1.19 |
dihydrolipoyl dehydrogenase activity | 1 | -1.4 | -1.14 | 2.27 | -1.25 | -1.48 | 1.94 | -1.5 |
dihydrolipoyllysine-residue succinyltransferase activity | 1 | 1.27 | -1.02 | 1.79 | -1.24 | 1.05 | 3.95 | -1.37 |
dihydroorotase activity | 1 | -1.12 | 1.14 | 1.63 | 1.21 | 1.33 | 1.0 | 1.05 |
dihydroorotate dehydrogenase activity | 2 | -1.09 | 1.44 | 1.03 | 1.31 | -1.02 | -1.29 | -1.1 |
6,7-dihydropteridine reductase activity | 1 | 2.26 | 1.17 | 1.35 | 1.12 | 1.23 | 1.64 | 1.14 |
dihydropyrimidinase activity | 1 | -1.0 | 1.2 | 1.11 | 1.02 | 1.13 | 1.01 | 1.16 |
dihydroorotate oxidase activity | 2 | -1.09 | 1.44 | 1.03 | 1.31 | -1.02 | -1.29 | -1.1 |
dihydrouracil dehydrogenase (NAD+) activity | 1 | -2.4 | 1.52 | -1.09 | 1.53 | -1.18 | -2.54 | -1.54 |
dimethylallyltranstransferase activity | 2 | 2.38 | 1.13 | 2.21 | -1.02 | 1.58 | 1.4 | 1.7 |
diphosphomevalonate decarboxylase activity | 1 | 2.36 | -1.19 | -1.1 | 1.02 | -1.17 | 1.09 | 1.24 |
diphthine synthase activity | 1 | 1.75 | 1.22 | 1.1 | 1.3 | 1.08 | -1.18 | -1.03 |
dodecenoyl-CoA delta-isomerase activity | 5 | 1.65 | 1.02 | -1.16 | 1.25 | 1.08 | 1.17 | -1.36 |
dopachrome isomerase activity | 2 | 2.9 | -1.22 | -1.25 | -1.08 | -1.28 | 3.34 | -1.14 |
dolichol kinase activity | 1 | -2.66 | 1.27 | -1.76 | 1.39 | 1.67 | -4.72 | -1.84 |
dolichyl-phosphate-mannose-protein mannosyltransferase activity | 2 | 1.57 | 1.01 | 1.07 | -1.18 | -1.11 | 1.61 | 1.23 |
dUTP diphosphatase activity | 1 | -1.36 | -1.27 | 1.07 | 1.7 | 1.82 | -3.47 | -2.13 |
peptidyl-lysine modification to hypusine | 2 | 1.15 | 1.07 | 1.04 | 1.07 | 1.11 | 1.08 | -1.05 |
deoxyhypusine biosynthetic process from spermidine, using deoxyhypusine synthase | 1 | -1.3 | 1.12 | 1.08 | 1.3 | 1.03 | -1.14 | -1.27 |
ecdysteroid UDP-glucosyltransferase activity | 2 | -2.06 | 1.41 | -1.15 | 1.08 | 1.07 | -2.31 | -1.09 |
electron-transferring-flavoprotein dehydrogenase activity | 1 | 2.09 | 1.59 | -1.41 | 1.19 | 1.36 | 1.02 | -1.19 |
endopeptidase activity | 433 | -1.75 | -1.28 | -1.35 | -1.08 | -1.23 | -1.79 | -1.45 |
ATP-dependent peptidase activity | 3 | -1.2 | 1.29 | 1.23 | 1.11 | 1.07 | 1.26 | 1.04 |
aminopeptidase activity | 36 | -2.28 | -1.12 | -1.52 | 1.05 | 1.14 | -1.43 | -1.98 |
metalloexopeptidase activity | 41 | -2.37 | -1.56 | -1.46 | 1.02 | -1.31 | -2.4 | -1.85 |
carboxypeptidase activity | 35 | -2.91 | -1.85 | -1.55 | -1.01 | -1.63 | -3.14 | -1.86 |
metallocarboxypeptidase activity | 24 | -4.15 | -2.21 | -1.86 | -1.01 | -1.57 | -4.07 | -2.61 |
serine-type carboxypeptidase activity | 11 | -1.26 | -1.29 | -1.05 | -1.03 | -1.8 | -1.77 | 1.1 |
aspartic-type endopeptidase activity | 19 | -1.6 | -1.03 | 1.15 | -1.16 | -1.46 | -1.86 | -1.32 |
calcium-dependent cysteine-type endopeptidase activity | 4 | 2.12 | 1.16 | 1.44 | 1.14 | 1.21 | 1.24 | 1.16 |
apoptotic process | 69 | 1.05 | 1.06 | 1.22 | 1.08 | 1.24 | -1.05 | 1.11 |
lysosome | 28 | -2.58 | -1.1 | -2.35 | 1.15 | -1.08 | -2.06 | -3.03 |
cysteine-type peptidase activity | 43 | -1.18 | -1.07 | 1.14 | -1.01 | 1.29 | -1.03 | -1.06 |
dipeptidyl-peptidase activity | 13 | -1.05 | 1.04 | -1.41 | 1.07 | 1.08 | -1.08 | 1.15 |
pyroglutamyl-peptidase activity | 2 | 2.37 | -1.16 | 1.04 | -1.04 | 1.14 | 1.57 | 1.04 |
ubiquitin thiolesterase activity | 27 | 1.19 | 1.22 | 1.57 | 1.17 | 1.42 | 1.39 | 1.24 |
metalloendopeptidase activity | 79 | -1.34 | -1.11 | -1.09 | 1.01 | 1.06 | -1.1 | -1.21 |
dipeptidase activity | 7 | -1.14 | -1.08 | -1.07 | 1.19 | 1.09 | -1.2 | -1.2 |
mitochondrion | 480 | 1.05 | 1.07 | 1.13 | 1.06 | 1.11 | 1.38 | -1.19 |
metallopeptidase activity | 153 | -1.78 | -1.24 | -1.3 | 1.02 | -1.0 | -1.44 | -1.51 |
peptidyl-dipeptidase activity | 6 | -1.43 | -1.17 | -1.51 | -1.07 | 1.03 | 1.0 | -1.19 |
vacuole | 54 | -2.1 | -1.04 | -1.32 | -1.01 | -1.13 | -1.28 | -1.9 |
serine-type peptidase activity | 288 | -2.24 | -1.4 | -1.61 | -1.12 | -1.45 | -2.28 | -1.59 |
tripeptidyl-peptidase activity | 2 | -2.48 | 1.24 | -1.3 | 1.26 | 1.28 | -1.53 | -1.15 |
threonine-type endopeptidase activity | 23 | 1.34 | -1.02 | 1.1 | 1.11 | 1.12 | -1.15 | -1.1 |
peptidase activity | 576 | -1.77 | -1.28 | -1.36 | -1.05 | -1.15 | -1.74 | -1.45 |
enoyl-CoA hydratase activity | 5 | 1.01 | 1.21 | -1.01 | 1.14 | 1.18 | -1.41 | -1.2 |
epoxide hydrolase activity | 3 | -2.11 | 1.3 | -1.14 | -1.06 | -1.44 | -4.35 | 1.38 |
estradiol 17-beta-dehydrogenase activity | 2 | 1.13 | -1.01 | -1.43 | 1.15 | 1.17 | -1.17 | -1.46 |
ethanolamine kinase activity | 2 | 1.11 | 1.13 | 1.36 | 1.19 | 1.43 | 2.57 | 1.13 |
ethanolamine-phosphate cytidylyltransferase activity | 1 | 1.81 | -1.85 | 1.07 | -1.42 | 1.03 | 1.7 | 2.82 |
ethanolaminephosphotransferase activity | 1 | -1.35 | 1.28 | 1.66 | 1.08 | 1.2 | 1.32 | 1.18 |
farnesyltranstransferase activity | 2 | 1.07 | 1.18 | 1.54 | 1.21 | 1.32 | 1.31 | -1.04 |
fatty acid synthase activity | 8 | 1.58 | -1.38 | -1.32 | -1.5 | -1.29 | 1.18 | 1.72 |
[acyl-carrier-protein] S-acetyltransferase activity | 2 | 3.49 | -1.07 | -1.08 | -1.15 | 1.4 | 1.97 | 2.1 |
[acyl-carrier-protein] S-malonyltransferase activity | 3 | 2.14 | -1.05 | -1.1 | -1.07 | 1.17 | 1.47 | 1.42 |
3-oxoacyl-[acyl-carrier-protein] synthase activity | 3 | 2.25 | -1.02 | -1.08 | -1.11 | 1.15 | 1.9 | 1.44 |
3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity | 2 | 3.49 | -1.07 | -1.08 | -1.15 | 1.4 | 1.97 | 2.1 |
3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity | 2 | 3.49 | -1.07 | -1.08 | -1.15 | 1.4 | 1.97 | 2.1 |
enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity | 2 | 3.49 | -1.07 | -1.08 | -1.15 | 1.4 | 1.97 | 2.1 |
oleoyl-[acyl-carrier-protein] hydrolase activity | 2 | 3.49 | -1.07 | -1.08 | -1.15 | 1.4 | 1.97 | 2.1 |
fatty-acyl-CoA synthase activity | 1 | 2.47 | -1.2 | -1.84 | 1.79 | 2.31 | -2.71 | -1.43 |
ferroxidase activity | 3 | -1.88 | -2.6 | -2.43 | -2.04 | 1.07 | -1.41 | 2.03 |
iron ion transmembrane transporter activity | 7 | 1.31 | -1.87 | -2.05 | -1.74 | -1.19 | 1.52 | 1.79 |
ferredoxin-NADP+ reductase activity | 1 | -1.19 | 1.24 | 1.2 | 1.43 | 1.53 | -1.12 | -1.13 |
tetrahydrofolylpolyglutamate synthase activity | 2 | -1.63 | 1.22 | -1.26 | 1.27 | -1.21 | -1.7 | -1.32 |
S-(hydroxymethyl)glutathione dehydrogenase activity | 1 | 1.29 | 1.1 | 1.03 | 1.22 | 1.29 | 1.66 | -1.14 |
formate-tetrahydrofolate ligase activity | 1 | -2.72 | 1.36 | -1.4 | 1.55 | -1.7 | -1.17 | -2.58 |
fructose-2,6-bisphosphate 2-phosphatase activity | 1 | 1.09 | -1.34 | 2.59 | -1.04 | 1.14 | 3.38 | -1.06 |
fructose-bisphosphate aldolase activity | 1 | 1.83 | 1.08 | -1.27 | -1.04 | 1.23 | 2.05 | 1.42 |
fumarate hydratase activity | 4 | -1.03 | 1.03 | -1.06 | -1.09 | -1.22 | 1.2 | -1.26 |
fumarylacetoacetase activity | 1 | 2.81 | -1.06 | -1.21 | -1.09 | 1.58 | 2.01 | -1.24 |
geranyltranstransferase activity | 2 | 2.38 | 1.13 | 2.21 | -1.02 | 1.58 | 1.4 | 1.7 |
glucosamine-6-phosphate deaminase activity | 1 | -1.22 | 1.14 | 1.64 | 1.24 | 2.02 | -2.96 | -2.72 |
glucosamine 6-phosphate N-acetyltransferase activity | 1 | 1.02 | 1.09 | -1.02 | 1.16 | 1.08 | -1.06 | 2.5 |
glucose dehydrogenase activity | 4 | 2.07 | -1.33 | -1.32 | -1.38 | -1.39 | 2.15 | -1.49 |
glucose-6-phosphate dehydrogenase activity | 2 | 1.97 | -1.14 | -2.0 | -1.18 | -1.53 | 1.18 | 1.65 |
glucose-6-phosphatase activity | 1 | 1.02 | 1.09 | 1.02 | 1.0 | -1.15 | -1.1 | -1.14 |
glucose-6-phosphate isomerase activity | 1 | 4.0 | 1.26 | -2.38 | -1.3 | -1.5 | 3.87 | 2.36 |
glucosylceramidase activity | 3 | -3.7 | -1.06 | -2.39 | 1.57 | -1.6 | -3.65 | -2.05 |
glutamate 5-kinase activity | 1 | -29.94 | 1.93 | -2.31 | -1.05 | -1.13 | -7.63 | 1.24 |
glutamate-5-semialdehyde dehydrogenase activity | 1 | -29.94 | 1.93 | -2.31 | -1.05 | -1.13 | -7.63 | 1.24 |
glutamate decarboxylase activity | 2 | 1.13 | -1.03 | -1.11 | 1.07 | -1.17 | -1.16 | -1.18 |
glutamate dehydrogenase (NAD+) activity | 1 | -1.32 | -1.9 | 1.3 | -2.14 | 3.35 | 4.87 | -4.48 |
glutamate dehydrogenase [NAD(P)+] activity | 2 | -1.13 | -1.34 | 1.15 | -1.41 | 1.89 | 2.28 | -2.14 |
glutamate synthase (NADPH) activity | 1 | 2.14 | 1.19 | 1.24 | 1.03 | -1.73 | 3.68 | 2.51 |
glutamate-ammonia ligase activity | 2 | 1.91 | -1.99 | 2.01 | -1.44 | 1.52 | -1.73 | -1.25 |
glutamate-cysteine ligase activity | 2 | -1.84 | 1.49 | -1.21 | 1.04 | -1.06 | 1.03 | 1.54 |
glutamine-fructose-6-phosphate transaminase (isomerizing) activity | 2 | -1.0 | -1.44 | 1.48 | -1.44 | 1.38 | 1.11 | 2.78 |
glutaryl-CoA dehydrogenase activity | 1 | -1.51 | -1.6 | -1.42 | 1.8 | -1.74 | 2.0 | -2.55 |
glutathione-disulfide reductase activity | 1 | -1.86 | 1.42 | -1.95 | 1.12 | 1.15 | -1.81 | 1.13 |
glutathione synthase activity | 1 | -4.56 | 1.3 | -1.17 | 1.44 | -1.72 | -2.63 | -1.17 |
glutathione transferase activity | 36 | -1.24 | 1.1 | 1.04 | -1.09 | -1.01 | -1.48 | -1.09 |
glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity | 3 | 1.41 | -1.11 | -1.14 | -1.08 | -1.06 | 1.76 | 1.01 |
glycerol-3-phosphate O-acyltransferase activity | 2 | 3.16 | -1.05 | -1.54 | 1.04 | 2.3 | -1.34 | 1.05 |
glycerol-3-phosphate dehydrogenase [NAD+] activity | 2 | 1.2 | 1.12 | -1.49 | 1.16 | 1.79 | -1.21 | -1.08 |
glycerol-3-phosphate dehydrogenase activity | 5 | -1.02 | -1.05 | 1.01 | 1.08 | 1.13 | 1.19 | -1.09 |
glycerol kinase activity | 5 | 1.42 | -1.01 | 1.08 | 1.36 | 1.35 | 1.01 | -1.3 |
glycine hydroxymethyltransferase activity | 1 | 4.17 | -1.15 | 1.23 | 1.12 | 1.08 | 1.16 | -1.19 |
glycogen (starch) synthase activity | 1 | 3.34 | -1.14 | 1.48 | -1.05 | 1.39 | 2.94 | 1.3 |
glycine decarboxylation via glycine cleavage system | 1 | 1.73 | -1.01 | 1.7 | -1.04 | 1.38 | 3.31 | -1.03 |
glycine dehydrogenase (decarboxylating) activity | 1 | -1.37 | -1.08 | -1.16 | -1.21 | -1.14 | 1.68 | -1.06 |
glycolipid mannosyltransferase activity | 1 | -1.85 | 1.22 | -1.04 | 1.31 | 1.1 | -2.17 | 1.06 |
glycylpeptide N-tetradecanoyltransferase activity | 1 | -1.49 | 1.29 | 1.71 | 1.24 | 1.7 | 1.05 | 1.0 |
guanosine-diphosphatase activity | 1 | -1.51 | 1.28 | -1.3 | 1.09 | -1.1 | -3.57 | 1.37 |
guanylate cyclase activity | 13 | -1.19 | -1.02 | -1.04 | 1.02 | -1.07 | -1.19 | -1.11 |
guanylate kinase activity | 5 | 3.22 | 1.04 | 1.21 | -1.15 | 1.05 | 2.62 | 1.29 |
receptor binding | 174 | 1.06 | -1.15 | -1.03 | -1.09 | 1.07 | 1.13 | 1.05 |
cell adhesion | 161 | 1.22 | -1.06 | 1.07 | -1.06 | 1.21 | 1.38 | 1.25 |
integral to membrane | 1123 | -1.03 | -1.03 | -1.04 | -1.04 | -1.01 | 1.02 | -1.0 |
cell adhesion molecule binding | 17 | -1.29 | -1.01 | 1.2 | -1.06 | 1.34 | -1.06 | 1.2 |
helicase activity | 105 | 1.14 | 1.19 | 1.33 | 1.17 | 1.34 | 1.27 | 1.17 |
heme oxygenase (decyclizing) activity | 1 | 2.0 | 1.05 | 2.09 | 1.06 | 1.46 | 2.34 | 1.12 |
heparan sulfate 2-O-sulfotransferase activity | 2 | 2.25 | 1.13 | 1.26 | 1.01 | 1.22 | 1.54 | 1.62 |
hexaprenyldihydroxybenzoate methyltransferase activity | 1 | -1.1 | 1.09 | 1.22 | 1.29 | 1.3 | 1.24 | -1.16 |
hexokinase activity | 4 | -1.31 | 1.0 | -1.96 | 1.11 | 1.37 | 1.21 | -1.77 |
histidine decarboxylase activity | 1 | 1.05 | 1.13 | 1.16 | 1.21 | 1.16 | 1.14 | 1.09 |
histone acetyltransferase activity | 13 | 1.18 | 1.17 | 1.35 | 1.18 | 1.29 | 1.36 | 1.21 |
histone deacetylase activity | 8 | 1.29 | 1.14 | 1.07 | 1.21 | 1.24 | 1.41 | 1.17 |
holocytochrome-c synthase activity | 1 | 1.66 | 1.03 | 1.71 | 1.06 | 1.0 | 2.28 | -1.41 |
homogentisate 1,2-dioxygenase activity | 1 | -1.11 | -1.1 | -1.19 | 1.12 | -1.15 | -1.2 | -1.15 |
hyalurononglucosaminidase activity | 1 | 1.16 | 1.5 | 1.47 | 1.26 | 1.67 | 1.16 | 1.31 |
hydroxyacylglutathione hydrolase activity | 1 | -2.43 | 1.25 | -1.81 | 1.44 | 1.13 | -2.07 | -1.36 |
hydroxymethylbilane synthase activity | 1 | -1.1 | 1.02 | -1.19 | -1.23 | -1.41 | 1.01 | -1.14 |
hydroxymethylglutaryl-CoA lyase activity | 1 | -1.23 | 1.82 | 1.48 | 1.33 | 1.52 | 1.63 | 1.08 |
hydroxymethylglutaryl-CoA synthase activity | 1 | 1.84 | -1.29 | 1.3 | -1.14 | 1.76 | 1.59 | 1.19 |
iduronate-2-sulfatase activity | 1 | 1.62 | 1.05 | 1.28 | 1.01 | 1.11 | 1.28 | 1.12 |
inorganic diphosphatase activity | 3 | 1.21 | -1.0 | 1.05 | 1.15 | 1.08 | 1.12 | -1.14 |
phosphatidylinositol phosphate kinase activity | 6 | -1.3 | 1.22 | 1.48 | 1.12 | 1.58 | 1.08 | 1.01 |
phosphatidylinositol kinase activity | 5 | -1.09 | 1.17 | 1.62 | 1.11 | 1.75 | 1.32 | 1.12 |
phosphatidylinositol bisphosphate kinase activity | 3 | -1.46 | 1.15 | 1.53 | 1.18 | 1.77 | -1.09 | -1.14 |
1-phosphatidylinositol 4-kinase activity | 2 | 1.44 | 1.21 | 1.76 | 1.02 | 1.71 | 2.28 | 1.63 |
1-phosphatidylinositol-4-phosphate 5-kinase activity | 3 | -1.16 | 1.29 | 1.43 | 1.06 | 1.4 | 1.27 | 1.16 |
phosphatidylinositol phospholipase C activity | 2 | 2.58 | 1.12 | 1.89 | -1.08 | 1.02 | 1.84 | 1.76 |
phosphatidylinositol bisphosphate phosphatase activity | 3 | 1.28 | 1.18 | 1.39 | 1.05 | 1.29 | 1.32 | 1.32 |
phosphatidylinositol trisphosphate phosphatase activity | 1 | 2.96 | 1.13 | 1.75 | -1.2 | 1.98 | 1.94 | 1.75 |
phosphatidylinositol monophosphate phosphatase activity | 2 | -1.31 | 1.16 | 1.29 | 1.21 | -1.01 | 1.04 | -1.19 |
inositol phosphate phosphatase activity | 13 | 1.85 | -1.04 | -1.08 | -1.1 | 1.15 | 1.89 | 1.3 |
phosphatidylinositol-3-phosphatase activity | 1 | -1.51 | 1.05 | 1.08 | 1.24 | -1.11 | -1.13 | -1.35 |
inositol-1,4-bisphosphate 1-phosphatase activity | 1 | 3.45 | -1.15 | 1.32 | 1.0 | -1.07 | 1.6 | -1.16 |
phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity | 1 | -1.07 | 1.22 | 1.09 | 1.37 | -1.04 | -1.17 | -1.02 |
inositol trisphosphate phosphatase activity | 6 | 1.66 | 1.07 | 1.37 | -1.03 | 1.33 | 2.5 | 1.26 |
inositol-polyphosphate 5-phosphatase activity | 3 | 1.23 | 1.22 | 1.55 | 1.08 | 1.34 | 1.47 | 1.38 |
isocitrate dehydrogenase activity | 7 | 1.09 | 1.14 | 1.28 | -1.23 | 1.01 | 1.93 | 1.09 |
isocitrate dehydrogenase (NAD+) activity | 6 | 1.03 | 1.08 | 1.46 | -1.19 | 1.02 | 2.18 | 1.06 |
isocitrate dehydrogenase (NADP+) activity | 1 | 1.5 | 1.55 | -1.65 | -1.56 | -1.01 | -1.09 | 1.26 |
isopentenyl-diphosphate delta-isomerase activity | 1 | 3.32 | -1.02 | 1.27 | 1.26 | 1.27 | 1.92 | 1.53 |
juvenile-hormone esterase activity | 1 | 1.2 | -1.02 | -1.01 | -1.01 | 1.01 | -1.01 | -1.05 |
ketohexokinase activity | 4 | 1.16 | 1.19 | 1.03 | 1.01 | 1.17 | 1.1 | -1.01 |
lactate dehydrogenase activity | 2 | 1.05 | 1.2 | 1.7 | -1.34 | -1.08 | -2.44 | 1.33 |
L-lactate dehydrogenase activity | 2 | 1.05 | 1.2 | 1.7 | -1.34 | -1.08 | -2.44 | 1.33 |
lactoylglutathione lyase activity | 1 | -1.59 | 1.09 | -1.01 | 1.22 | -1.05 | -1.39 | -1.43 |
leukotriene-A4 hydrolase activity | 1 | -1.74 | 1.11 | -2.01 | 1.51 | 1.27 | -1.87 | -1.55 |
lipoprotein lipase activity | 5 | -2.69 | -1.1 | -1.42 | 1.06 | 1.23 | -1.76 | -1.32 |
long-chain-acyl-CoA dehydrogenase activity | 2 | 1.45 | 1.45 | -1.3 | -1.02 | 1.11 | 1.33 | -1.15 |
long-chain fatty acid-CoA ligase activity | 7 | 1.81 | -1.3 | -1.35 | 1.09 | 1.2 | -1.91 | -1.26 |
lysine N-acetyltransferase activity | 1 | 1.11 | 1.34 | 1.12 | 1.23 | 1.07 | 1.27 | 1.32 |
malic enzyme activity | 4 | -1.07 | 1.26 | 1.14 | -1.52 | -1.06 | 1.05 | 1.65 |
malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity | 4 | -1.07 | 1.26 | 1.14 | -1.52 | -1.06 | 1.05 | 1.65 |
mannose-1-phosphate guanylyltransferase activity | 2 | -2.09 | 1.14 | 1.2 | 1.25 | 1.24 | -1.89 | 1.17 |
mannose-6-phosphate isomerase activity | 2 | 3.41 | 1.03 | 1.33 | -1.05 | -1.02 | 3.9 | 1.9 |
methenyltetrahydrofolate cyclohydrolase activity | 2 | 1.63 | -1.3 | -1.28 | -1.04 | -1.47 | 2.82 | -1.53 |
methionine adenosyltransferase activity | 1 | 1.6 | 1.05 | 1.23 | -1.23 | 1.41 | 1.78 | 1.98 |
methionyl-tRNA formyltransferase activity | 1 | 1.38 | 1.09 | 1.78 | 1.2 | 1.53 | 2.7 | -1.25 |
mRNA (guanine-N7-)-methyltransferase activity | 1 | 1.22 | 1.12 | 1.34 | 1.19 | 1.11 | -1.08 | 1.0 |
mRNA guanylyltransferase activity | 1 | 1.69 | 1.28 | 1.3 | 1.3 | 1.17 | 1.5 | 1.34 |
methylcrotonoyl-CoA carboxylase activity | 2 | 1.38 | 1.49 | 1.32 | 1.28 | 1.37 | 1.61 | 1.17 |
methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity | 1 | 2.55 | -3.49 | -3.06 | -4.0 | -1.9 | 6.63 | -1.86 |
methylenetetrahydrofolate dehydrogenase (NAD+) activity | 1 | 7.21 | -2.31 | -1.17 | -1.68 | -1.27 | 9.3 | 1.1 |
methylenetetrahydrofolate dehydrogenase (NADP+) activity | 2 | 1.63 | -1.3 | -1.28 | -1.04 | -1.47 | 2.82 | -1.53 |
methylenetetrahydrofolate reductase (NADPH) activity | 1 | 1.73 | -1.17 | -1.14 | -1.13 | -1.11 | 2.12 | -1.29 |
methylmalonate-semialdehyde dehydrogenase (acylating) activity | 1 | -1.74 | 1.44 | -1.08 | -1.1 | -1.07 | 1.5 | 1.28 |
mevalonate kinase activity | 1 | 1.42 | 1.16 | 1.14 | 1.22 | 1.05 | 1.2 | -1.02 |
monooxygenase activity | 35 | 1.52 | -1.2 | -1.23 | -1.13 | -1.16 | -1.04 | 1.06 |
N,N-dimethylaniline monooxygenase activity | 2 | 1.33 | 1.51 | -1.79 | -1.37 | -1.35 | 1.43 | 1.59 |
dopamine beta-monooxygenase activity | 3 | 1.25 | 1.07 | -1.02 | -1.01 | 1.04 | 1.12 | 1.05 |
ecdysone 20-monooxygenase activity | 1 | -1.22 | -1.23 | 1.13 | -1.06 | 1.31 | -1.16 | -1.34 |
kynurenine 3-monooxygenase activity | 1 | 1.05 | 1.0 | -1.01 | 1.01 | -1.05 | -1.09 | -1.05 |
monophenol monooxygenase activity | 3 | 1.29 | 1.11 | -1.09 | -1.0 | -1.13 | -1.11 | -1.01 |
peptidylglycine monooxygenase activity | 1 | 2.74 | 1.3 | 1.75 | 1.08 | 1.98 | 1.97 | 2.28 |
phenylalanine 4-monooxygenase activity | 2 | 1.24 | -1.3 | -1.46 | -1.42 | -1.18 | 2.11 | -1.36 |
tryptophan 5-monooxygenase activity | 2 | 1.24 | -1.3 | -1.46 | -1.42 | -1.18 | 2.11 | -1.36 |
tyrosine 3-monooxygenase activity | 1 | -1.05 | -1.1 | 1.05 | 1.12 | -1.1 | -1.1 | 1.78 |
inositol-3-phosphate synthase activity | 1 | 1.86 | -1.46 | -1.12 | -1.51 | 1.13 | 1.83 | 1.71 |
nicotinate-nucleotide diphosphorylase (carboxylating) activity | 1 | 8.31 | 1.05 | -1.79 | -1.54 | -1.19 | 1.17 | 2.54 |
nicotinate phosphoribosyltransferase activity | 1 | 8.31 | 1.05 | -1.79 | -1.54 | -1.19 | 1.17 | 2.54 |
nitric-oxide synthase activity | 1 | 1.08 | 1.06 | 1.02 | 1.1 | 1.05 | -1.07 | -1.02 |
nuclease activity | 79 | 1.35 | 1.08 | 1.23 | 1.13 | 1.28 | 1.26 | 1.07 |
endonuclease activity | 38 | 1.44 | 1.02 | 1.21 | 1.09 | 1.25 | 1.3 | 1.05 |
endodeoxyribonuclease activity | 15 | 1.39 | -1.02 | 1.1 | -1.02 | 1.11 | 1.13 | 1.04 |
endoribonuclease activity | 19 | 1.25 | 1.08 | 1.3 | 1.22 | 1.37 | 1.23 | -1.0 |
ribonuclease H activity | 2 | -1.13 | 1.13 | 1.07 | 1.39 | 1.3 | -1.08 | -1.14 |
ribonuclease III activity | 4 | 1.01 | 1.12 | 1.7 | -1.0 | 1.33 | 1.5 | 1.2 |
ribonuclease P activity | 3 | 1.41 | -1.04 | -1.03 | 1.27 | 1.1 | 1.0 | -1.33 |
exonuclease activity | 33 | 1.16 | 1.17 | 1.21 | 1.21 | 1.29 | 1.11 | 1.04 |
exodeoxyribonuclease activity | 7 | -1.09 | 1.11 | 1.04 | 1.05 | 1.14 | -1.05 | -1.01 |
deoxyribonuclease II activity | 1 | 3.57 | -3.74 | -3.12 | -4.14 | -2.27 | -1.33 | 4.32 |
exoribonuclease activity | 18 | 1.38 | 1.17 | 1.2 | 1.26 | 1.28 | 1.2 | 1.08 |
5'-3' exoribonuclease activity | 2 | -1.11 | 1.53 | 1.16 | 1.33 | 1.34 | -1.11 | 1.19 |
poly(A)-specific ribonuclease activity | 2 | 1.33 | 1.15 | 1.69 | 1.2 | 1.62 | 2.01 | 1.48 |
deoxyribonuclease activity | 24 | 1.28 | 1.02 | 1.14 | 1.01 | 1.16 | 1.13 | 1.07 |
ribonuclease activity | 41 | 1.37 | 1.11 | 1.23 | 1.22 | 1.32 | 1.27 | 1.04 |
tRNA-specific ribonuclease activity | 4 | 1.4 | 1.02 | -1.04 | 1.26 | 1.1 | -1.04 | -1.24 |
nucleoside diphosphate kinase activity | 4 | 1.0 | 1.09 | 1.36 | 1.22 | 1.36 | 1.06 | -1.14 |
nucleotide diphosphatase activity | 2 | 1.11 | 1.19 | 1.38 | 1.17 | 1.36 | 1.15 | -1.0 |
octanol dehydrogenase activity | 1 | 1.29 | 1.1 | 1.03 | 1.22 | 1.29 | 1.66 | -1.14 |
hydrolase activity, hydrolyzing O-glycosyl compounds | 93 | -1.83 | -1.29 | -2.4 | -1.22 | -1.47 | -1.78 | -1.26 |
alpha,alpha-trehalase activity | 3 | -2.73 | 1.23 | -2.68 | 1.17 | -1.22 | -2.41 | 1.01 |
alpha-amylase activity | 2 | -34.84 | -2.22 | -3.89 | 2.13 | -10.58 | -52.06 | -2.46 |
alpha-galactosidase activity | 1 | -4.17 | 1.11 | -1.19 | -1.11 | -1.3 | -2.49 | 3.87 |
alpha-glucosidase activity | 13 | -7.82 | -1.11 | -3.92 | 1.01 | -2.19 | -4.92 | -2.34 |
alpha-mannosidase activity | 9 | -14.64 | -1.14 | -7.39 | 1.54 | -1.15 | -14.33 | -25.61 |
alpha-L-fucosidase activity | 1 | -1.1 | -1.19 | -1.53 | -1.9 | -1.86 | -1.28 | 7.99 |
alpha-N-acetylglucosaminidase activity | 1 | -1.03 | -1.29 | -2.28 | -2.21 | -1.93 | 20.24 | 3.19 |
beta-N-acetylhexosaminidase activity | 4 | 2.6 | -1.04 | -1.38 | 1.02 | 1.14 | -1.03 | 1.23 |
beta-galactosidase activity | 2 | -4.22 | 1.94 | -2.65 | -1.31 | -2.65 | -1.75 | -2.68 |
beta-glucuronidase activity | 2 | -2.98 | 1.22 | 1.8 | 1.28 | 1.95 | -1.65 | 1.15 |
beta-mannosidase activity | 1 | -5.95 | 1.18 | 1.25 | 1.37 | 1.4 | -3.3 | -1.02 |
chitinase activity | 17 | -1.5 | -2.2 | -3.34 | -2.35 | -1.62 | 1.11 | 2.06 |
mannosyl-oligosaccharide 1,2-alpha-mannosidase activity | 5 | 1.56 | 1.24 | -1.27 | -1.11 | -1.07 | 2.0 | 1.29 |
mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity | 2 | 2.21 | -1.18 | -1.12 | 1.09 | -1.0 | 4.22 | 1.53 |
mannosyl-oligosaccharide glucosidase activity | 1 | 1.11 | 1.54 | -1.06 | 1.25 | 1.09 | -1.47 | 1.06 |
oligo-1,6-glucosidase activity | 1 | -7.77 | -4.97 | -3.61 | 4.46 | -5.62 | -8.7 | -6.61 |
oligosaccharyl transferase activity | 5 | -1.28 | 1.21 | 1.16 | 1.14 | 1.2 | -1.13 | 1.35 |
dolichyl-diphosphooligosaccharide-protein glycotransferase activity | 2 | -2.3 | 1.16 | -1.02 | 1.14 | 1.1 | -1.42 | 1.33 |
dolichyl-phosphate beta-glucosyltransferase activity | 1 | -1.18 | 1.16 | 1.9 | 1.06 | 1.5 | -1.14 | 1.68 |
dolichyl-phosphate beta-D-mannosyltransferase activity | 1 | 1.01 | 1.25 | 1.35 | 1.09 | 1.77 | -1.32 | 1.33 |
ornithine decarboxylase activity | 2 | -1.3 | -1.56 | -1.58 | -1.19 | -1.51 | 1.68 | -1.8 |
ornithine-oxo-acid transaminase activity | 2 | -3.39 | 1.33 | -4.62 | 1.16 | 1.17 | -3.49 | 1.2 |
orotate phosphoribosyltransferase activity | 1 | 1.61 | 1.06 | 1.09 | 1.15 | 1.38 | -1.09 | 1.01 |
orotidine-5'-phosphate decarboxylase activity | 1 | 1.61 | 1.06 | 1.09 | 1.15 | 1.38 | -1.09 | 1.01 |
oxoglutarate dehydrogenase (succinyl-transferring) activity | 2 | -2.58 | 1.25 | 1.08 | -1.04 | 1.34 | -1.08 | -1.45 |
pantothenate kinase activity | 1 | 2.17 | 1.37 | -1.41 | 1.23 | 1.4 | -1.72 | 1.12 |
pantetheine-phosphate adenylyltransferase activity | 1 | -1.07 | 1.17 | -1.47 | 1.46 | 1.3 | -2.5 | -1.32 |
peptide alpha-N-acetyltransferase activity | 2 | -1.32 | 1.41 | 1.74 | 1.19 | 1.16 | -1.05 | -1.05 |
peptide-aspartate beta-dioxygenase activity | 1 | 1.22 | -1.0 | 1.11 | -1.0 | 1.04 | 1.19 | -1.11 |
cyclosporin A binding | 1 | -1.56 | 1.12 | -1.6 | -1.09 | -1.49 | -1.56 | -1.26 |
peroxidase activity | 22 | -1.07 | -1.02 | -1.12 | -1.17 | -1.19 | -1.23 | 1.01 |
glutathione peroxidase activity | 8 | -1.36 | 1.09 | -1.0 | -1.35 | -1.25 | -2.14 | 1.1 |
phosphatidate cytidylyltransferase activity | 1 | 3.07 | 1.1 | 2.07 | -1.42 | 3.13 | -1.11 | 1.4 |
phosphatidylserine decarboxylase activity | 1 | 2.68 | -1.15 | 1.36 | 1.05 | 1.26 | 2.6 | 1.26 |
phosphoacetylglucosamine mutase activity | 1 | -2.86 | 1.51 | 1.12 | 1.09 | 1.09 | -5.18 | 1.1 |
phosphoenolpyruvate carboxykinase activity | 2 | -2.6 | -1.77 | 1.37 | -1.78 | 2.07 | 1.05 | -1.67 |
phosphoenolpyruvate carboxykinase (GTP) activity | 2 | -2.6 | -1.77 | 1.37 | -1.78 | 2.07 | 1.05 | -1.67 |
phosphoglucomutase activity | 1 | 3.54 | -1.2 | -2.31 | -1.28 | -1.28 | 4.52 | 1.34 |
phosphomannomutase activity | 3 | -1.23 | -1.01 | 1.33 | 1.13 | 1.42 | -1.37 | 1.13 |
phosphogluconate dehydrogenase (decarboxylating) activity | 4 | 1.7 | 1.24 | -1.62 | -1.03 | -1.05 | 1.36 | 1.59 |
phosphoglycerate dehydrogenase activity | 2 | 2.82 | -1.08 | -1.11 | 1.42 | -1.05 | 1.77 | -1.02 |
phosphoglycerate kinase activity | 2 | 1.52 | -1.04 | -1.22 | 1.01 | -1.05 | 1.8 | -1.0 |
phosphoglycerate mutase activity | 4 | 1.53 | -1.02 | -1.23 | -1.07 | -1.15 | 1.51 | 1.11 |
phospholipase activity | 42 | -2.02 | -1.32 | -1.4 | -1.24 | -1.44 | -1.94 | -1.19 |
lysophospholipase activity | 5 | -1.5 | -1.08 | -1.31 | -1.5 | -1.48 | 1.02 | 1.77 |
phospholipase A2 activity | 10 | 1.72 | -1.05 | -1.16 | -1.1 | -1.05 | -1.02 | 1.07 |
extracellular region | 527 | -1.12 | -1.32 | -1.37 | -1.26 | -1.26 | -1.16 | 1.03 |
calcium-dependent phospholipase A2 activity | 1 | -1.04 | -1.03 | -1.01 | -1.13 | -1.15 | 1.09 | -1.0 |
cytosol | 213 | 1.26 | 1.07 | 1.15 | 1.06 | 1.18 | 1.2 | 1.04 |
calcium-independent phospholipase A2 activity | 2 | 1.71 | 1.33 | 1.36 | 1.12 | 1.41 | 1.4 | 1.33 |
phospholipase C activity | 8 | 1.4 | 1.12 | 1.15 | -1.01 | -1.08 | 1.08 | 1.32 |
phosphomevalonate kinase activity | 1 | 2.16 | -1.1 | 1.03 | -1.13 | 1.06 | 2.2 | 1.18 |
phosphopantothenate--cysteine ligase activity | 1 | -1.95 | 1.39 | 1.68 | 1.01 | 1.49 | -1.24 | 1.08 |
phosphopantothenoylcysteine decarboxylase activity | 1 | 3.72 | -1.03 | 1.39 | 1.15 | 1.52 | 2.47 | 1.16 |
phosphopyruvate hydratase activity | 1 | 1.97 | 1.06 | -1.39 | -1.17 | -1.32 | 2.59 | 1.17 |
phosphoribosylamine-glycine ligase activity | 1 | 1.35 | 1.17 | 1.22 | 1.29 | 1.23 | 1.38 | 1.07 |
phosphoribosylaminoimidazole carboxylase activity | 2 | -1.17 | -1.46 | -1.46 | -1.15 | -1.17 | 1.65 | -1.07 |
phosphoribosylaminoimidazolesuccinocarboxamide synthase activity | 2 | -1.17 | -1.46 | -1.46 | -1.15 | -1.17 | 1.65 | -1.07 |
phosphoribosylformylglycinamidine cyclo-ligase activity | 1 | 1.35 | 1.17 | 1.22 | 1.29 | 1.23 | 1.38 | 1.07 |
phosphoribosylformylglycinamidine synthase activity | 1 | -1.91 | 1.54 | -1.81 | 1.0 | -1.5 | -1.22 | 1.08 |
phosphoribosylaminoimidazolecarboxamide formyltransferase activity | 1 | -1.39 | 1.0 | -1.49 | -1.01 | -1.06 | 1.63 | -1.09 |
phosphoribosylglycinamide formyltransferase activity | 1 | 1.35 | 1.17 | 1.22 | 1.29 | 1.23 | 1.38 | 1.07 |
phosphorylase activity | 1 | 2.98 | -1.08 | 1.5 | -1.31 | 1.12 | 4.86 | 1.33 |
phosphoserine phosphatase activity | 1 | 2.48 | 1.99 | -2.53 | -1.16 | 1.91 | 2.86 | 1.87 |
O-phospho-L-serine:2-oxoglutarate aminotransferase activity | 1 | 2.63 | -1.02 | -1.9 | 1.11 | -1.04 | 2.51 | 1.93 |
poly(ADP-ribose) glycohydrolase activity | 1 | 1.16 | 1.03 | 1.19 | 1.34 | 1.67 | -1.1 | 1.01 |
polynucleotide 5'-phosphatase activity | 1 | 1.69 | 1.28 | 1.3 | 1.3 | 1.17 | 1.5 | 1.34 |
polynucleotide adenylyltransferase activity | 6 | 1.11 | 1.12 | 1.2 | 1.08 | 1.07 | 1.17 | 1.11 |
polypeptide N-acetylgalactosaminyltransferase activity | 14 | -1.29 | -1.23 | -1.25 | -1.28 | -1.26 | -1.61 | 1.75 |
polyribonucleotide nucleotidyltransferase activity | 1 | -1.12 | 1.21 | 1.17 | 1.13 | 1.3 | 1.14 | -1.02 |
porphobilinogen synthase activity | 1 | -2.33 | 1.65 | -1.72 | 1.07 | -2.09 | -1.28 | -1.14 |
iron ion transport | 7 | 1.59 | -1.3 | -1.22 | -1.23 | -1.14 | 1.5 | 1.12 |
procollagen-proline 4-dioxygenase activity | 26 | -1.01 | -1.0 | -1.08 | -1.01 | -1.13 | -1.04 | -1.05 |
proline dehydrogenase activity | 1 | 2.07 | -7.1 | -4.47 | -7.74 | -3.15 | 31.25 | -1.33 |
propionyl-CoA carboxylase activity | 1 | 1.48 | 1.28 | 1.32 | 1.05 | 1.07 | 1.16 | -1.01 |
prenyltransferase activity | 12 | -1.12 | 1.14 | 1.32 | 1.1 | 1.21 | -1.16 | 1.28 |
protein farnesyltransferase activity | 1 | -1.83 | -1.28 | -1.22 | 1.05 | -1.01 | -1.04 | 2.75 |
protein geranylgeranyltransferase activity | 6 | -1.57 | 1.19 | 1.22 | 1.14 | 1.21 | -1.62 | 1.21 |
CAAX-protein geranylgeranyltransferase activity | 2 | -2.28 | 1.15 | 1.11 | 1.06 | 1.05 | -2.22 | 1.78 |
Rab geranylgeranyltransferase activity | 4 | -1.3 | 1.2 | 1.28 | 1.18 | 1.3 | -1.38 | -1.0 |
protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity | 1 | -2.13 | 1.18 | 1.09 | 1.41 | 1.8 | -1.71 | -1.76 |
protein kinase activity | 255 | 1.18 | 1.11 | 1.27 | 1.06 | 1.27 | 1.34 | 1.17 |
protein histidine kinase activity | 3 | 1.12 | -1.13 | 1.03 | -1.08 | 1.69 | 1.52 | -1.14 |
protein serine/threonine kinase activity | 183 | 1.12 | 1.13 | 1.33 | 1.08 | 1.3 | 1.3 | 1.15 |
transmembrane receptor protein serine/threonine kinase activity | 5 | -1.03 | 1.52 | 1.48 | 1.18 | 1.61 | 1.07 | 1.49 |
DNA-dependent protein kinase activity | 1 | 1.33 | 1.54 | 1.93 | 1.1 | 1.72 | 1.13 | 1.74 |
AMP-activated protein kinase activity | 3 | 1.06 | 1.32 | 1.11 | 1.03 | -1.06 | 1.31 | 1.11 |
calmodulin-dependent protein kinase activity | 8 | 2.03 | 1.07 | 1.21 | 1.02 | 1.3 | 2.02 | 1.5 |
elongation factor-2 kinase activity | 2 | 1.62 | 1.17 | 1.62 | -1.04 | 1.48 | 1.47 | 1.77 |
myosin light chain kinase activity | 4 | 1.66 | -1.14 | 1.36 | -1.04 | 1.61 | 1.38 | 1.02 |
phosphorylase kinase activity | 1 | 1.92 | 1.23 | 1.07 | 1.1 | 1.35 | 3.19 | 1.58 |
cyclic nucleotide-dependent protein kinase activity | 6 | -1.04 | -1.05 | 1.23 | -1.15 | 1.2 | 2.46 | 1.34 |
cAMP-dependent protein kinase activity | 3 | 1.72 | -1.04 | 1.4 | -1.32 | 1.33 | 4.14 | 1.26 |
cGMP-dependent protein kinase activity | 3 | -1.85 | -1.05 | 1.07 | 1.01 | 1.09 | 1.46 | 1.42 |
cyclin-dependent protein kinase activity | 15 | 1.14 | 1.12 | 1.32 | 1.15 | 1.42 | 1.04 | -1.02 |
protein kinase C activity | 7 | 1.66 | -1.04 | 1.77 | -1.14 | 1.06 | 2.51 | 1.12 |
calcium-dependent protein kinase C activity | 3 | 1.12 | 1.04 | 2.13 | -1.07 | 1.01 | 3.21 | -1.04 |
receptor signaling protein serine/threonine kinase activity | 31 | -1.19 | 1.17 | 1.44 | 1.1 | 1.38 | 1.04 | 1.15 |
G-protein coupled receptor kinase activity | 3 | 1.16 | 1.4 | 1.53 | 1.09 | 1.29 | 1.52 | 1.29 |
JUN kinase activity | 2 | -1.09 | 1.03 | 1.52 | 1.15 | 1.41 | -1.08 | 1.01 |
JUN kinase kinase kinase activity | 2 | 1.23 | 1.27 | 1.56 | 1.2 | 1.54 | 1.23 | 1.3 |
MAP kinase activity | 9 | -1.46 | 1.12 | 1.25 | 1.14 | 1.35 | -1.25 | 1.02 |
MAP kinase kinase activity | 3 | -1.23 | 1.23 | 1.34 | 1.19 | 1.4 | 1.25 | 1.23 |
MAP kinase kinase kinase activity | 5 | -1.39 | 1.21 | 1.48 | 1.15 | 1.82 | 1.09 | 1.04 |
MAPK/ERK kinase kinase activity | 1 | 1.83 | 1.46 | 1.17 | -1.02 | 1.24 | 1.79 | 1.33 |
ribosomal protein S6 kinase activity | 1 | -2.62 | 1.78 | 1.7 | 1.33 | 1.66 | 1.52 | 1.3 |
protein serine/threonine/tyrosine kinase activity | 7 | -1.0 | 1.17 | 1.32 | 1.17 | 1.33 | 1.18 | 1.15 |
protein tyrosine kinase activity | 43 | 1.39 | 1.05 | 1.14 | 1.01 | 1.19 | 1.42 | 1.33 |
transmembrane receptor protein tyrosine kinase activity | 21 | 1.55 | -1.07 | 1.14 | -1.01 | 1.13 | 1.58 | 1.42 |
non-membrane spanning protein tyrosine kinase activity | 7 | 1.37 | 1.16 | 1.77 | 1.12 | 1.46 | 1.64 | 1.42 |
receptor signaling protein tyrosine kinase activity | 3 | -1.0 | 1.08 | -1.13 | -1.05 | -1.16 | -1.03 | -1.05 |
protein-L-isoaspartate (D-aspartate) O-methyltransferase activity | 1 | 2.93 | 1.03 | 1.2 | 1.19 | 1.05 | 1.97 | 1.02 |
protein-lysine 6-oxidase activity | 2 | -1.01 | 1.14 | -1.1 | 1.01 | -1.1 | -1.06 | -1.07 |
phosphoprotein phosphatase activity | 86 | 1.24 | 1.12 | 1.24 | 1.06 | 1.2 | 1.31 | 1.16 |
protein serine/threonine phosphatase activity | 42 | 1.25 | 1.09 | 1.29 | 1.04 | 1.19 | 1.37 | 1.15 |
calcium-dependent protein serine/threonine phosphatase activity | 6 | 1.52 | -1.02 | 1.2 | 1.05 | 1.13 | 1.24 | 1.06 |
protein tyrosine phosphatase activity | 39 | 1.24 | 1.12 | 1.28 | 1.06 | 1.27 | 1.3 | 1.17 |
non-membrane spanning protein tyrosine phosphatase activity | 5 | 1.49 | 1.12 | 1.2 | 1.1 | 1.4 | 1.22 | 1.1 |
prenylated protein tyrosine phosphatase activity | 1 | 1.54 | 1.27 | 2.19 | -1.23 | 1.74 | 3.0 | 1.51 |
receptor signaling protein tyrosine phosphatase activity | 3 | 2.8 | -1.06 | 1.33 | -1.06 | 1.35 | 3.49 | 1.47 |
oxygen-dependent protoporphyrinogen oxidase activity | 2 | -1.11 | 1.24 | 1.36 | 1.38 | 1.3 | 1.17 | -1.16 |
pseudouridylate synthase activity | 3 | 1.57 | 1.31 | 1.17 | 1.55 | 1.45 | 1.03 | 1.08 |
purine-nucleoside phosphorylase activity | 2 | 1.43 | 1.02 | 1.21 | 1.12 | 1.16 | -1.08 | 1.07 |
pyridoxamine-phosphate oxidase activity | 3 | 1.93 | 1.06 | -1.17 | 1.32 | 1.07 | 1.07 | -1.07 |
pyrimidodiazepine synthase activity | 4 | 1.29 | 1.17 | 1.1 | 1.04 | 1.18 | -1.03 | 1.04 |
pyrroline-5-carboxylate reductase activity | 2 | -1.77 | 1.27 | -1.94 | 1.07 | -1.03 | -1.14 | -1.01 |
pyruvate carboxylase activity | 1 | 2.41 | -1.07 | -1.67 | 1.11 | -2.11 | 1.65 | 1.08 |
pyruvate dehydrogenase activity | 3 | -1.02 | 1.01 | 1.31 | 1.1 | -1.0 | 1.57 | -1.25 |
pyruvate dehydrogenase (acetyl-transferring) activity | 3 | -1.02 | 1.01 | 1.31 | 1.1 | -1.0 | 1.57 | -1.25 |
pyruvate dehydrogenase (acetyl-transferring) kinase activity | 1 | 1.67 | -1.54 | 1.2 | -1.13 | 7.02 | 3.44 | 1.09 |
[pyruvate dehydrogenase (lipoamide)] phosphatase activity | 1 | 1.78 | 1.13 | 1.46 | 1.23 | 1.08 | 1.92 | 1.02 |
dihydrolipoyllysine-residue acetyltransferase activity | 1 | 1.23 | 1.19 | 1.96 | -1.07 | 1.35 | 3.33 | 1.11 |
pyruvate kinase activity | 7 | 1.18 | 1.01 | 1.0 | -1.0 | -1.04 | 1.2 | -1.0 |
retinal isomerase activity | 1 | 1.12 | -1.01 | 1.14 | 1.06 | 1.09 | 1.14 | -1.06 |
retinol dehydrogenase activity | 1 | -1.07 | 1.02 | 1.03 | -1.03 | -1.28 | 1.11 | -1.06 |
ribokinase activity | 2 | -1.21 | 1.07 | -1.3 | 1.1 | -1.27 | -1.38 | -1.12 |
ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor | 2 | -2.27 | -1.06 | 1.44 | 1.36 | 1.87 | -1.61 | -1.54 |
ribose phosphate diphosphokinase activity | 2 | 2.41 | 1.04 | 1.7 | -1.06 | 1.1 | 2.9 | 1.34 |
ribulose-phosphate 3-epimerase activity | 1 | 3.69 | 1.12 | -1.44 | 1.15 | 1.15 | 1.38 | 1.6 |
ribose-5-phosphate isomerase activity | 1 | 2.8 | 1.42 | -1.73 | 1.16 | 1.1 | 1.26 | 1.25 |
saccharopine dehydrogenase activity | 1 | 1.21 | 1.36 | -1.07 | 1.24 | -1.06 | 1.55 | 1.4 |
saccharopine dehydrogenase (NAD+, L-lysine-forming) activity | 1 | 1.21 | 1.36 | -1.07 | 1.24 | -1.06 | 1.55 | 1.4 |
selenide, water dikinase activity | 2 | 1.76 | 1.25 | 1.23 | 1.04 | 1.04 | 1.62 | -1.07 |
sepiapterin reductase activity | 3 | 2.14 | -1.76 | -1.79 | -1.65 | -1.36 | 2.93 | -1.29 |
serine C-palmitoyltransferase activity | 2 | -2.24 | 1.07 | 2.48 | 1.17 | 1.31 | -1.71 | -1.18 |
serine-pyruvate transaminase activity | 1 | 1.1 | -1.81 | -2.08 | -1.81 | -1.6 | 3.21 | -1.83 |
spermidine synthase activity | 2 | 1.05 | 1.2 | 1.25 | 1.18 | 1.33 | 1.44 | -1.0 |
sphingomyelin phosphodiesterase activity | 5 | -5.07 | -3.51 | -4.56 | 1.49 | -1.12 | -3.62 | -4.08 |
stearoyl-CoA 9-desaturase activity | 7 | -1.4 | 1.15 | -1.2 | 1.26 | 1.01 | -1.67 | -1.18 |
sterol esterase activity | 1 | -139.1 | -18.6 | -1.99 | 2.08 | -24.32 | -152.96 | -197.4 |
sterol O-acyltransferase activity | 3 | -2.3 | -1.64 | -1.24 | 1.46 | 1.26 | -1.59 | -2.16 |
succinate-CoA ligase activity | 6 | 1.06 | -1.06 | 1.08 | -1.08 | 1.02 | 1.3 | -1.31 |
succinate-CoA ligase (ADP-forming) activity | 5 | 1.09 | -1.04 | 1.18 | -1.15 | -1.09 | 1.43 | -1.27 |
succinate-CoA ligase (GDP-forming) activity | 3 | 1.16 | -1.04 | -1.07 | -1.04 | 1.11 | 1.22 | -1.42 |
succinate-semialdehyde dehydrogenase activity | 1 | -2.19 | 1.37 | 2.06 | 1.34 | 1.0 | 1.58 | -1.11 |
sulfate adenylyltransferase activity | 1 | -2.63 | 1.06 | 1.41 | 1.07 | 1.11 | -1.64 | -1.02 |
sulfate adenylyltransferase (ATP) activity | 1 | -2.63 | 1.06 | 1.41 | 1.07 | 1.11 | -1.64 | -1.02 |
sulfinoalanine decarboxylase activity | 1 | -1.56 | 1.66 | -7.28 | 1.14 | -1.03 | -3.47 | 1.18 |
superoxide dismutase activity | 5 | 1.45 | 1.15 | -1.15 | 1.12 | -1.07 | 1.37 | -1.06 |
thiamine diphosphokinase activity | 2 | -1.04 | 1.3 | 1.02 | 1.32 | 1.14 | -1.17 | -1.06 |
thioredoxin-disulfide reductase activity | 2 | -1.32 | 1.3 | -1.35 | 1.1 | 1.1 | -1.38 | 1.15 |
thiosulfate sulfurtransferase activity | 1 | 1.15 | -1.38 | 2.62 | 1.38 | 1.04 | -1.42 | -1.83 |
threonine aldolase activity | 1 | 1.44 | -1.1 | -1.93 | 1.6 | -1.06 | 1.8 | -2.26 |
L-threonine ammonia-lyase activity | 1 | -3.81 | -2.74 | -2.14 | -1.15 | 11.07 | -1.69 | -3.46 |
thymidine kinase activity | 1 | 1.02 | 1.09 | 1.32 | 1.32 | 1.3 | -1.29 | -1.13 |
thymidylate kinase activity | 1 | 1.27 | 1.13 | 1.91 | 1.21 | 1.41 | -1.17 | -1.08 |
thymidylate synthase activity | 1 | -1.63 | -1.08 | 1.19 | 1.46 | 1.72 | -2.2 | -2.17 |
sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity | 1 | 3.18 | 1.11 | -3.27 | 1.02 | -1.44 | -1.1 | 1.46 |
transketolase activity | 2 | 2.03 | 1.17 | -1.56 | 1.02 | 1.12 | 1.44 | 1.62 |
transposase activity | 1 | 1.07 | -1.04 | -1.16 | 1.02 | 1.48 | -1.27 | -1.22 |
trehalose-phosphatase activity | 2 | 5.88 | -2.14 | -1.49 | -1.62 | 1.02 | 4.6 | 1.12 |
triglyceride lipase activity | 38 | -3.83 | -1.33 | -1.88 | -1.09 | -1.77 | -4.41 | -2.22 |
tRNA (5-methylaminomethyl-2-thiouridylate)-methyltransferase activity | 1 | 1.03 | 1.15 | 1.06 | 1.36 | -1.06 | -1.46 | -1.19 |
tRNA (guanine-N2-)-methyltransferase activity | 1 | 1.09 | 1.31 | 1.08 | 1.21 | 1.15 | 1.13 | 1.18 |
aminoacyl-tRNA ligase activity | 40 | -1.07 | 1.26 | 1.26 | 1.14 | 1.18 | 1.05 | 1.09 |
alanine-tRNA ligase activity | 3 | -1.05 | 1.37 | 1.07 | 1.17 | 1.09 | 1.18 | 1.07 |
arginine-tRNA ligase activity | 3 | 1.35 | 1.15 | 1.32 | 1.15 | 1.24 | 1.15 | 1.05 |
aspartate-tRNA ligase activity | 1 | -1.97 | 1.61 | 1.28 | -1.18 | 1.45 | -1.88 | 1.38 |
asparagine-tRNA ligase activity | 2 | -1.04 | 1.15 | 1.12 | 1.09 | 1.19 | -1.05 | 1.03 |
cysteine-tRNA ligase activity | 2 | -1.01 | 1.37 | 1.43 | 1.08 | 1.22 | 1.24 | 1.76 |
glutamate-tRNA ligase activity | 3 | -1.23 | 1.31 | 1.44 | 1.01 | 1.37 | 1.11 | 1.37 |
glutamine-tRNA ligase activity | 1 | 1.03 | 1.27 | 1.03 | 1.21 | 1.05 | 1.24 | 1.09 |
glycine-tRNA ligase activity | 3 | 1.01 | 1.17 | 1.37 | 1.21 | 1.21 | 1.27 | -1.07 |
histidine-tRNA ligase activity | 1 | -1.32 | 1.37 | -1.07 | 1.31 | -1.14 | -1.74 | -1.19 |
isoleucine-tRNA ligase activity | 2 | 1.35 | 1.22 | 1.54 | 1.02 | 1.38 | 1.61 | 1.38 |
leucine-tRNA ligase activity | 2 | -1.17 | 1.4 | 1.1 | 1.12 | 1.07 | 1.1 | 1.24 |
lysine-tRNA ligase activity | 1 | 1.12 | 1.29 | 1.39 | 1.11 | 1.29 | 1.02 | 1.14 |
methionine-tRNA ligase activity | 2 | -1.59 | 1.18 | 1.28 | 1.38 | 1.17 | -1.27 | -1.03 |
phenylalanine-tRNA ligase activity | 3 | -1.16 | 1.27 | 1.38 | 1.24 | 1.13 | -1.0 | -1.14 |
proline-tRNA ligase activity | 2 | -1.08 | 1.19 | 1.31 | 1.06 | 1.32 | 1.47 | 1.15 |
serine-tRNA ligase activity | 3 | -1.3 | 1.34 | 1.25 | 1.17 | 1.28 | -1.22 | -1.0 |
threonine-tRNA ligase activity | 2 | -1.65 | 1.24 | 1.06 | 1.13 | -1.08 | -1.17 | 1.02 |
tryptophan-tRNA ligase activity | 2 | 1.09 | 1.09 | 1.24 | 1.11 | 1.12 | 1.12 | 1.03 |
tyrosine-tRNA ligase activity | 2 | 1.14 | 1.27 | 1.29 | 1.14 | 1.19 | 1.03 | -1.04 |
valine-tRNA ligase activity | 2 | -1.62 | 1.31 | 1.29 | 1.15 | 1.04 | -1.25 | 1.17 |
tryptophan 2,3-dioxygenase activity | 1 | 1.33 | -1.46 | -1.36 | -1.56 | -1.39 | 2.84 | -1.33 |
tubulin-tyrosine ligase activity | 11 | 1.17 | 1.01 | -1.01 | 1.04 | -1.02 | 1.1 | 1.04 |
tyrosine decarboxylase activity | 2 | 2.12 | -1.17 | -1.18 | -1.17 | 1.11 | 1.9 | -1.07 |
L-tyrosine:2-oxoglutarate aminotransferase activity | 1 | 1.14 | 1.12 | -1.09 | -1.15 | 1.09 | -1.15 | -1.05 |
ubiquitin activating enzyme activity | 3 | 1.07 | 1.19 | 1.42 | 1.25 | 1.55 | 1.31 | 1.05 |
ubiquitin-protein ligase activity | 83 | 1.15 | 1.18 | 1.45 | 1.14 | 1.34 | 1.23 | 1.22 |
ubiquitin-specific protease activity | 8 | 1.17 | 1.21 | 1.8 | 1.18 | 1.58 | 1.96 | 1.41 |
uracil DNA N-glycosylase activity | 2 | 2.91 | -1.23 | -1.13 | -1.34 | 1.04 | 2.88 | 1.17 |
uracil phosphoribosyltransferase activity | 1 | 1.85 | 1.12 | 1.41 | 1.03 | 1.01 | 1.67 | 1.33 |
urate oxidase activity | 1 | 3.87 | -2.08 | -2.11 | -2.0 | -1.26 | -1.05 | -1.64 |
uridine kinase activity | 2 | 4.18 | -1.72 | 1.72 | -1.65 | -1.27 | 3.76 | 1.43 |
uridine phosphorylase activity | 3 | -2.2 | -1.73 | 1.35 | -1.47 | -1.37 | -2.19 | 1.39 |
uroporphyrinogen-III synthase activity | 2 | 1.15 | -1.11 | -1.12 | 1.02 | -1.09 | 1.11 | -1.25 |
uroporphyrinogen decarboxylase activity | 1 | 2.27 | -1.08 | -1.25 | 1.43 | 1.04 | 1.18 | 1.26 |
xanthine dehydrogenase activity | 2 | 1.25 | 1.78 | -1.17 | -1.32 | -1.19 | -1.3 | 1.66 |
xanthine oxidase activity | 1 | 1.38 | 1.39 | -1.09 | 1.59 | 1.39 | -1.89 | 1.34 |
xylulokinase activity | 2 | 1.23 | 1.04 | -1.16 | -1.08 | 1.26 | 1.41 | 1.22 |
enzyme inhibitor activity | 101 | 1.28 | -1.39 | -1.39 | -1.37 | -1.17 | 1.33 | 1.03 |
protein kinase inhibitor activity | 6 | 1.32 | 1.13 | 1.13 | 1.05 | 1.2 | 1.27 | 1.35 |
cyclin-dependent protein kinase inhibitor activity | 2 | 1.97 | -1.0 | 1.05 | 1.02 | 1.15 | 1.58 | 1.04 |
protein phosphatase inhibitor activity | 7 | 1.59 | -1.08 | -1.01 | -1.03 | 1.27 | 1.27 | -1.01 |
protein serine/threonine phosphatase inhibitor activity | 1 | 1.57 | 1.1 | -1.11 | 1.22 | 1.13 | -1.01 | -1.25 |
endopeptidase inhibitor activity | 73 | 1.41 | -1.48 | -1.45 | -1.49 | -1.3 | 1.51 | 1.04 |
serine-type endopeptidase inhibitor activity | 58 | 1.2 | -1.48 | -1.57 | -1.54 | -1.37 | 1.38 | -1.05 |
cysteine-type endopeptidase inhibitor activity | 6 | 3.11 | -1.78 | -1.05 | -1.54 | -1.18 | 1.44 | 1.41 |
signal transducer activity | 443 | 1.09 | 1.01 | 1.1 | 1.0 | 1.08 | 1.12 | 1.06 |
receptor activity | 428 | 1.12 | -1.03 | 1.04 | -1.02 | 1.04 | 1.12 | 1.04 |
ecdysteroid hormone receptor activity | 2 | 1.39 | 1.12 | 1.31 | 1.09 | 1.22 | 1.45 | 1.35 |
thyroid hormone receptor activity | 2 | -1.28 | 1.12 | 1.08 | -1.12 | -1.1 | -1.03 | -1.04 |
transmembrane signaling receptor activity | 332 | 1.1 | -1.02 | 1.05 | -1.02 | 1.03 | 1.1 | 1.04 |
acetylcholine-activated cation-selective channel activity | 9 | -1.07 | 1.01 | -1.02 | -1.03 | -1.09 | -1.06 | -1.03 |
GABA-A receptor activity | 3 | 1.07 | 1.04 | 1.03 | -1.04 | -1.11 | -1.02 | -1.07 |
carbohydrate binding | 166 | -1.92 | -1.36 | -1.53 | -1.23 | -1.33 | -1.85 | -1.01 |
cytokine receptor activity | 1 | 1.28 | 1.03 | 1.08 | -1.21 | -1.11 | 1.23 | -1.01 |
boss receptor activity | 1 | 2.09 | -1.24 | -1.34 | -1.08 | -1.33 | -1.62 | 1.07 |
Wnt-activated receptor activity | 5 | 1.17 | 1.03 | 1.52 | -1.14 | 1.66 | -1.04 | 1.31 |
Wnt receptor signaling pathway | 56 | 1.24 | 1.03 | 1.2 | -1.03 | 1.29 | 1.38 | 1.28 |
Wnt receptor signaling pathway, calcium modulating pathway | 2 | 1.15 | 1.15 | 1.16 | 1.02 | 1.3 | 1.14 | 2.54 |
G-protein coupled receptor activity | 168 | 1.06 | -1.03 | 1.05 | -1.02 | 1.01 | 1.02 | -1.02 |
adrenergic receptor activity | 2 | -1.09 | 1.2 | -1.08 | -1.0 | -1.18 | -1.21 | -1.07 |
bombesin receptor activity | 2 | 1.03 | 1.12 | 1.37 | -1.03 | -1.15 | 1.42 | 1.13 |
calcitonin receptor activity | 5 | 1.36 | -1.25 | 1.11 | -1.21 | 1.02 | -1.07 | 1.56 |
cholecystokinin receptor activity | 2 | -1.2 | -1.05 | 1.02 | -1.05 | -1.23 | -1.25 | -1.17 |
dopamine receptor activity | 4 | -1.05 | 1.04 | -1.1 | 1.03 | -1.07 | -1.17 | -1.14 |
G-protein coupled GABA receptor activity | 4 | -1.05 | 1.06 | -1.02 | 1.01 | -1.05 | -1.07 | -1.16 |
galanin receptor activity | 1 | -1.14 | 1.16 | 1.12 | 1.07 | 1.38 | -1.13 | 1.15 |
gonadotropin-releasing hormone receptor activity | 2 | 1.14 | 1.03 | 1.06 | 1.02 | -1.01 | -1.0 | -1.03 |
ionotropic glutamate receptor activity | 35 | 1.11 | -1.01 | 1.02 | -1.04 | -1.06 | -1.02 | -1.03 |
alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity | 2 | -1.07 | -1.07 | -1.18 | -1.06 | -1.13 | -1.05 | -1.13 |
N-methyl-D-aspartate selective glutamate receptor activity | 5 | -2.2 | 1.03 | -1.01 | -1.04 | -1.02 | -1.52 | 1.05 |
leukotriene receptor activity | 1 | 1.34 | 1.16 | 1.19 | 1.06 | 1.04 | 1.4 | -1.06 |
neuropeptide Y receptor activity | 6 | -1.12 | -1.28 | 1.15 | -1.08 | 1.23 | 2.07 | -1.01 |
olfactory receptor activity | 58 | -1.05 | 1.02 | -1.02 | 1.02 | -1.07 | -1.04 | -1.08 |
opioid receptor activity | 1 | 1.11 | 1.13 | -1.05 | 1.1 | 1.01 | 1.15 | 1.06 |
octopamine receptor activity | 6 | 1.21 | 1.06 | 1.02 | 1.02 | 1.02 | 1.0 | 1.01 |
serotonin receptor activity | 3 | 1.27 | -1.02 | 1.07 | 1.0 | 1.01 | 1.11 | 1.03 |
somatostatin receptor activity | 2 | -1.22 | 1.13 | 1.03 | -1.13 | -1.24 | -1.37 | -1.14 |
tachykinin receptor activity | 6 | -1.02 | -1.12 | 1.07 | -1.2 | -1.05 | 1.79 | 1.44 |
vasopressin receptor activity | 1 | -1.03 | 1.09 | 1.19 | 1.15 | 1.1 | -1.1 |